spacer

GO Term History: Displaying 492 audit records for all terms for the date 2010-11-18

From (YYYY-MM-DD):
To (YYYY-MM-DD):
Period:
Category:
Terms:
Limit:
Date Specification

You can specify an explicit date range that you are interested in by setting the "From" and "To" parameters; this will limit the data displayed to those changes that were recorded within that (inclusive) date range.

Alternatively, you can use the "Period" parameter to view the GO term changes that occurred over a specific number of Day(s), Week(s), Month(s) or Year(s) before a specified date.

If you do not enter a "To" date, then the period will be relative to the current date. If, however, you do specify a "To" value, then the "Period" value will display records in the timeframe up to and including that specified date.

Category

You can use this field to specify what types of term changes you are interested in seeing.

Terms

You can enter a list of GO Terms in this field to limit the changes displayed. Please note that only changes made to directly listed terms will be displayed, not term descendants.

Limit

The default number of records returned is 500, however you can increase or decrease this limit. In order to prevent possible browser problems, the maximum upper limit is 10,000.

Introduction

This page displays the differences recorded in the full Gene Ontology OBO v1.2 file as audited by the UniProt-GOA database during its daily update cycle.
If there is any delay in uploading the current OBO file, the changes displayed and the date recorded for these changes may not correspond to when the changes to the OBO file were committed.

All changes

Timestamp GO ID GO Term Name Action Category Detail
2010-11-18 GO:0002450 B cell antigen processing and presentation Added DEFINITION The process in which a B cell expresses antigen (peptide or lipid) on its cell surface in association with an MHC protein complex.
2010-11-18 GO:0002457 T cell antigen processing and presentation Added DEFINITION The process in which a T cell expresses antigen (peptide or lipid) on its cell surface in association with an MHC protein complex.
2010-11-18 GO:0002489 antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent Added DEFINITION The process in which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC class Ib protein complex following intracellular transport via a TAP (transporter associated with antigen processing) pathway. The peptide is typically a fragment of a larger endogenous protein which has been degraded within the cell and is dependent on TAP transport from the cytosol to ER for association with the MHC class Ib molecule. Class Ib here refers to non-classical class I molecules, such as those of the HLA-E gene family.
2010-11-18 GO:0002491 antigen processing and presentation of endogenous peptide antigen via MHC class II Added DEFINITION The process in which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC class II protein complex. The peptide antigen is typically, but not always, processed from a whole protein.
2010-11-18 GO:0002680 pro-T cell lineage commitment Added DEFINITION The process in which a lymphoid progenitor cell becomes committed to becoming a pro-T cell.
2010-11-18 GO:0003003 follicular fluid formation in ovarian follicle antrum involved in fused antrum stage Added DEFINITION The ovulation cycle process in which one central cavity separating the oocyte/cumulus complex from mural granulosa and theca cells is formed as part of the fused antrum stage of oogenesis.
2010-11-18 GO:0003019 central nervous system control of baroreceptor feedback Added DEFINITION The neurological process in which nerve impulses arising in the aorta or the carotid sinuses travel to the medulla and reach the nucleus of tractus solaris.
2010-11-18 GO:0003021 detection of increased carbon dioxide by chemoreceptor signaling Added DEFINITION The process in which information about the levels of carbon dioxideare received and are converted to a molecular signal by chemoreceptors in the carotid bodies and the aortic bodies.
2010-11-18 GO:0003035 detection of increased carbon dioxide by carotid body chemoreceptor signaling Added DEFINITION The process in which information about the levels of carbon dioxide are received and are converted to a molecular signal by chemoreceptors in a carotid body.
2010-11-18 GO:2000242 negative regulation of reproductive process Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of reproductive process.
2010-11-18 GO:0003107 positive regulation of natriuresis by angiotensin Added DEFINITION The process in which angiotensin increases the rate of natriuresis indirectly via diuresis. Natriuresis is the process of renal sodium excretion.
2010-11-18 GO:0003109 positive regulation of the force of heart contraction by circulating norepinephrine Added DEFINITION The process in which the secretion of norepinephrine into the bloodstream modulates the force of heart muscle contraction.
2010-11-18 GO:0003111 positive regulation of heart rate by circulating epinephrine Added DEFINITION The process in which the secretion of epinephrine into the bloodstream increases the rate of heart muscle contraction.
2010-11-18 GO:0003159 morphogenesis of an endothelium Added DEFINITION The process in which the anatomical structure of an endothelium is generated and organized. An endothelium is an epithelium that lines an anatomical structure.
2010-11-18 GO:0018119 peptidyl-cysteine S-nitrosylation Added DEFINITION The covalent addition of a nitric oxide (NO) group to the sulphur (S) atom of a cysteine residue in a protein, to form peptidyl-S-nitrosyl-L-cysteine.
2010-11-18 GO:0018220 peptidyl-threonine palmitoylation Added DEFINITION The covalent attachment of a palmitoyl group to an oxygen (O) atom in a threonine residue to form peptidyl-O-palmitoyl-L-threonine.
2010-11-18 GO:0072362 regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter Added DEFINITION Any process that modulates the frequency, rate or extent of glycolysis by stopping, preventing, or reducing the frequency, rate or extent of transcription from an RNA polymerase II promoter.
2010-11-18 GO:2000168 negative regulation of planar cell polarity pathway involved in neural tube closure Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of planar cell polarity pathway involved in neural tube closure.
2010-11-18 GO:2000181 negative regulation of blood vessel morphogenesis Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of blood vessel morphogenesis.
2010-11-18 GO:2000186 negative regulation of phosphate transmembrane transport Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of phosphate transmembrane transport.
2010-11-18 GO:2000190 negative regulation of regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor.
2010-11-18 GO:2000212 negative regulation of glutamate metabolic process Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of glutamate metabolic process.
2010-11-18 GO:2000233 negative regulation of rRNA processing Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of rRNA processing.
2010-11-18 GO:2000236 negative regulation of tRNA processing Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of tRNA processing.
2010-11-18 GO:0001929 negative regulation of exocyst assembly Added DEFINITION Any process that stops, prevents, or reduces the rate or extent of exocyst assembly.
2010-11-18 GO:0002128 tRNA nucleoside ribose methylation Added DEFINITION The process that results in the modification of the sugar of a nucleoside in tRNA at the 2'O position.
2010-11-18 GO:0002175 protein localization to paranode region of axon Added DEFINITION A cellular protein localization process in which a protein is transported to, or maintained at, the paranode region of an axon.
2010-11-18 GO:0002201 somatic diversification of DSCAM-based immune receptors Added DEFINITION The somatic process that results in the generation of sequence diversity of the DSCAM-based immune receptors of insects.
2010-11-18 GO:0000769 syncytium formation by mitosis without cytokinesis Updated TERM syncytium formation by mitosis without cytokinesis
2010-11-18 GO:0072358 cardiovascular system development Added TERM cardiovascular system development
2010-11-18 GO:0072359 circulatory system development Added TERM circulatory system development
2010-11-18 GO:0072360 vascular cord development Added TERM vascular cord development
2010-11-18 GO:0072361 regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter Added TERM regulation of glycolysis by regulation of transcription from an RNA polymerase II promoter
2010-11-18 GO:0072362 regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter Added TERM regulation of glycolysis by negative regulation of transcription from an RNA polymerase II promoter
2010-11-18 GO:0072365 regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter Added TERM regulation of cellular ketone metabolic process by negative regulation of transcription from an RNA polymerase II promoter
2010-11-18 GO:0072366 regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter Added TERM regulation of cellular ketone metabolic process by positive regulation of transcription from an RNA polymerase II promoter
2010-11-18 GO:0072367 regulation of lipid transport by regulation of transcription from RNA polymerase II promoter Added TERM regulation of lipid transport by regulation of transcription from an RNA polymerase II promoter
2010-11-18 GO:0072368 regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter Added TERM regulation of lipid transport by negative regulation of transcription from an RNA polymerase II promoter
2010-11-18 GO:0072369 regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter Added TERM regulation of lipid transport by positive regulation of transcription from an RNA polymerase II promoter
2010-11-18 GO:0072363 regulation of glycolytic by positive regulation of transcription from RNA polymerase II promoter Added TERM regulation of glycolysis by positive regulation of transcription from an RNA polymerase II promoter
2010-11-18 GO:0072364 regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter Added TERM regulation of cellular ketone metabolic process by regulation of transcription from an RNA polymerase II promoter
2010-11-18 GO:0035605 peptidyl-cysteine S-nitrosylase activity Added TERM peptidyl-cysteine S-nitrosylase activity
2010-11-18 GO:0035606 peptidyl-cysteine S-trans-nitrosylation Added TERM peptidyl-cysteine S-trans-nitrosylation
2010-11-18 GO:0035607 fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development Added TERM fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development
2010-11-18 GO:0002504 antigen processing and presentation of peptide or polysaccharide antigen via MHC class II Added DEFINITION The process in which an antigen-presenting cell expresses antigen (peptide or polysaccharide) on its cell surface in association with an MHC class II protein complex.
2010-11-18 GO:0002344 B cell affinity maturation Added DEFINITION The process in which B cells produce antibodies with increased antigen affinity. This is accomplished by somatic hypermutation and selection for B cells which produce higher affinity antibodies to antigen.
2010-11-18 GO:0002363 alpha-beta T cell lineage commitment Added DEFINITION The process in which a pro-T cell becomes committed to becoming an alpha-beta T cell.
2010-11-18 GO:0002364 NK T cell lineage commitment Added DEFINITION The process in which a pro-T cell becomes committed to becoming an NK T cell.
2010-11-18 GO:0002468 dendritic cell antigen processing and presentation Added DEFINITION The process in which a dendritic cell expresses antigen (peptide or lipid) on its cell surface in association with an MHC protein complex.
2010-11-18 GO:0002471 monocyte antigen processing and presentation Added DEFINITION The process in which a monocyte expresses antigen (peptide or lipid) on its cell surface in association with an MHC protein complex.
2010-11-18 GO:0002478 antigen processing and presentation of exogenous peptide antigen Added DEFINITION The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC protein complex. The peptide is typically a fragment of a larger exogenous protein which has been degraded within the cell.
2010-11-18 GO:0002480 antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent Added DEFINITION The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class I protein complex following intracellular transport via a pathway not requiring TAP (transporter associated with antigen processing). The peptide is typically a fragment of a larger exogenous protein which has been degraded within the cell. Class I here refers to classical class I molecules.
2010-11-18 GO:0002486 antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent Added DEFINITION The process in which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC class I protein complex following intracellular transport via a TAP-independent ER pathway. The peptide is typically a fragment of a larger endogenous protein which has been degraded within the cell and becomes associated with the MHC class I molecule in the ER following transport from the cytosol via a TAP-independent pathway. Class I here refers to classical class I molecules.
2010-11-18 GO:0002487 antigen processing and presentation of endogenous peptide antigen via MHC class I via endolysosomal pathway Added DEFINITION The process in which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC class I protein complex. The peptide is typically a fragment of a larger endogenous protein which has been degraded within the cell and becomes associated with the MHC class I molecule in an endolysosome. Class I here refers to classical class I molecules.
2010-11-18 GO:0002490 antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-independent Added DEFINITION The process in which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC class Ib protein complex following intracellular transport via a pathway not requiring TAP (transporter associated with antigen processing). The peptide is typically a fragment of a larger endogenous protein which has been degraded within the cell. Class Ib here refers to non-classical class I molecules, such as those of the HLA-E gene family.
2010-11-18 GO:0002681 somatic recombination of T cell receptor gene segments Added DEFINITION The process in which T cell receptor genes are formed through recombination of the germline genetic elements, also known as T cell receptor gene segments.
2010-11-18 GO:0003029 detection of hypoxic conditions in blood by carotid body chemoreceptor signaling Added DEFINITION The process in which information about a lack of oxygen are received and are converted to a molecular signal by chemoreceptors in the carotid bodies.
2010-11-18 GO:0003069 vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure Added DEFINITION The process in which acetylcholine signaling causes vasodilation, resulting in a change in blood pressure.
2010-11-18 GO:0003098 tubuloglomerular feedback Added DEFINITION The process in which blood volume is regulated due to a change in the rate of glomerular filtration. This is accomplished by a feedback mechanism that senses changes in the juxtaglomerular apparatus.
2010-11-18 GO:0003101 regulation of systemic arterial blood pressure by circulatory epinephrine-norepinephrine Added DEFINITION The process in which epinephrine-norepinephrine modulate the force with which blood passes through the circulatory system.
2010-11-18 GO:0002563 somatic diversification of immune receptors via alternate splicing Added DEFINITION The process in which immune receptor genes are diversified through alternate splicing.
2010-11-18 GO:0003083 negative regulation of renal output by angiotensin Added DEFINITION The process in which angiotensin directly decreases the rate of natriuresis and diuresis in the kidney.
2010-11-18 GO:0003100 regulation of systemic arterial blood pressure by endothelin Added DEFINITION The process in which endothelin modulates the force with which blood passes through the circulatory system. Endothelin is a hormone that is released by the endothelium, and it is a vasoconstrictor.
2010-11-18 GO:0003128 heart field specification Added DEFINITION The process that results in the delineation of a specific region of the lateral mesoderm into the area in which the heart will develop.
2010-11-18 GO:0003143 embryonic heart tube morphogenesis Added DEFINITION The process in which the anatomical structures of the embryonic heart tube are generated and organized. Morphogenesis pertains to the creation of form. The embryonic heart tube is an epithelial tube that will give rise to the mature heart.
2010-11-18 GO:0003148 outflow tract septum morphogenesis Added DEFINITION The process in which the anatomical structures of the outflow tract septum are generated and organized. Morphogenesis pertains to the creation of form. The outflow tract septum is a partition in the outflow tract.
2010-11-18 GO:0007059 chromosome segregation Added DEFINITION The process by which genetic material, in the form of chromosomes, is organized into specific structures and then physically separated and apportioned to two or more sets. In eukaryotes, chromosome segregation begins with the alignment of chromosomes at the metaphase plate, includes chromosome separation, and ends when chromosomes have completed movement to the spindle poles.
2010-11-18 GO:0021764 amygdala development Added DEFINITION The progression of the amygdala over time from its initial formation until its mature state. The amygdala is an almond-shaped set of neurons in the medial temporal lobe of the brain that play a key role in processing emotions such as fear and pleasure.
2010-11-18 GO:0034119 negative regulation of erythrocyte aggregation Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate, or extent of erythrocyte aggregation.
2010-11-18 GO:0035607 fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development Added DEFINITION The series of molecular signals generated as a consequence of a fibroblast growth factor-type receptor binding to one of its physiological ligands, which contributes to the progression of the orbitofrontal cortex over time from its initial formation until its mature state.
2010-11-18 GO:0046918 N-terminal peptidyl-glycine N-palmitoylation Added DEFINITION The covalent attachment of a palmitoyl group to a nitrogen (N) atom in an N-terminal glycine residue to form N-palmitoyl-glycine.
2010-11-18 GO:2000143 negative regulation of DNA-templated transcription, initiation Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of transcription initiation.
2010-11-18 GO:2000192 negative regulation of fatty acid transport Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of fatty acid transport.
2010-11-18 GO:2000201 negative regulation of ribosomal subunit export from nucleus Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of ribosomal subunit export from nucleus.
2010-11-18 GO:2000207 negative regulation of ribosomal small subunit export from nucleus Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of ribosomal small subunit export from nucleus.
2010-11-18 GO:2000225 negative regulation of testosterone biosynthetic process Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of testosterone biosynthetic process.
2010-11-18 GO:2000245 negative regulation of FtsZ-dependent cytokinesis Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of cytokinesis by binary fission.
2010-11-18 GO:0001953 negative regulation of cell-matrix adhesion Added DEFINITION Any process that stops, prevents, or reduces the rate or extent of cell adhesion to the extracellular matrix.
2010-11-18 GO:0002202 somatic diversification of variable lymphocyte receptors of jawless fish Added DEFINITION The somatic process that results in the generation of sequence diversity of the variable lymphocyte receptors (VLR) of jawless fish.
2010-11-18 GO:0002206 gene conversion of immunoglobulin genes Added DEFINITION The somatic process in which immunoglobulin genes are diversified through the mechanism of gene conversion.
2010-11-18 GO:0002360 T cell lineage commitment Added DEFINITION The process in which a lymphoid progenitor cell becomes committed to becoming any type of T cell.
2010-11-18 GO:0002470 plasmacytoid dendritic cell antigen processing and presentation Added DEFINITION The process in which a plasmacytoid dendritic cell expresses antigen (peptide or lipid) on its cell surface in association with an MHC protein complex.
2010-11-18 GO:0002484 antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway Added DEFINITION The process in which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC class I protein complex following intracellular transport via an ER pathway. The peptide is typically a fragment of a larger endogenous protein which has been degraded within the cell and becomes associated with the MHC class I molecule in the ER. Class I here refers to classical class I molecules.
2010-11-18 GO:0002488 antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway Added DEFINITION The process in which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC class Ib protein complex following intracellular transport via an ER pathway. The peptide is typically a fragment of a larger endogenous protein which has been degraded within the cell and becomes associated with the MHC class Ib molecule in the ER. Class Ib here refers to non-classical class I molecules, such as those of the HLA-E gene family.
2010-11-18 GO:0002495 antigen processing and presentation of peptide antigen via MHC class II Added DEFINITION The process in which an antigen-presenting cell expresses a peptide antigen on its cell surface in association with an MHC class II protein complex. The peptide antigen is typically, but not always, processed from a whole protein.
2010-11-18 GO:0003002 regionalization Added DEFINITION The pattern specification process that results in the subdivision of an axis or axes in space to define an area or volume in which specific patterns of cell differentiation will take place or in which cells interpret a specific environment.
2010-11-18 GO:0003020 detection of reduced oxygen by chemoreceptor signaling Added DEFINITION The process in which information about the levels of oxygen are received and are converted to a molecular signal by chemoreceptors in the carotid bodies and the aortic bodies.
2010-11-18 GO:0003038 detection of reduced oxygen by aortic body chemoreceptor signaling Added DEFINITION The process in which information about the levels of oxygen are received and are converted to a molecular signal by chemoreceptors in an aortic body.
2010-11-18 GO:0003040 excitation of vasomotor center by aortic body chemoreceptor signaling Added DEFINITION The process in which the molecular signal from an aortic body is relayed to the vasomotor center, causing it to signal an increase arterial pressure.
2010-11-18 GO:0003058 hormonal regulation of the force of heart contraction Added DEFINITION The process in which the hormones modulates the force of heart muscle contraction. A hormone is one of a group of substances formed in very small amounts in one specialized organ or group of cells and carried (sometimes in the bloodstream) to another organ or group of cells, in the same organism, upon which they have a specific regulatory action.
2010-11-18 GO:0003064 regulation of heart rate by hormone Added DEFINITION The process in which the hormones modulates the rate of heart muscle contraction. A hormone is one of a group of substances formed in very small amounts in one specialized organ or group of cells and carried (sometimes in the bloodstream) to another organ or group of cells, in the same organism, upon which they have a specific regulatory action.
2010-11-18 GO:0003146 heart jogging Added DEFINITION The morphogenetic process in which the heart cone is displaced to the left with respect to the vector of the anterior-posterior axis.
2010-11-18 GO:0003149 membranous septum morphogenesis Added DEFINITION The process in which the membranous septum is generated and organized. The membranous septum is the upper part of ventricular septum. Morphogenesis pertains to the creation of form.
2010-11-18 GO:0002567 somatic diversification of FREP-based immune receptors Added DEFINITION The process that results in the generation of sequence diversity of the FREP-based immune receptors of snails.
2010-11-18 GO:0003022 detection of pH by chemoreceptor signaling Added DEFINITION The process in which information about the levels of hydrogen ions are received and are converted to a molecular signal by chemoreceptors in the carotid bodies and the aortic bodies.
2010-11-18 GO:0003041 excitation of vasomotor center by carotid body chemoreceptor signaling Added DEFINITION The process in which the molecular signal from a carotid body is relayed to the vasomotor center, causing it to signal an increase arterial pressure.
2010-11-18 GO:0003059 positive regulation of the force of heart contraction by epinephrine Added DEFINITION The process in which the secretion of epinephrine into the bloodstream or released from nerve endings modulates the force of heart muscle contraction.
2010-11-18 GO:0003150 muscular septum morphogenesis Added DEFINITION The process in which the muscular septum is generated and organized. The muscular septum is the lower part of the ventricular septum.
2010-11-18 GO:0003152 morphogenesis of an epithelial fold involved in embryonic heart tube formation Added DEFINITION The morphogenetic process in which an epithelial sheet bends along a linear axis, contributing to embryonic heart tube formation.
2010-11-18 GO:0018221 peptidyl-serine palmitoylation Added DEFINITION The covalent attachment of a palmitoyl group to an oxygen (O) atom in a serine residue to form peptidyl-O-palmitoyl-L-serine.
2010-11-18 GO:0033629 negative regulation of cell adhesion mediated by integrin Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate, or extent of cell adhesion mediated by integrin.
2010-11-18 GO:0034104 negative regulation of tissue remodeling Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate, or extent of tissue remodeling.
2010-11-18 GO:0034111 negative regulation of homotypic cell-cell adhesion Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate, or extent of homotypic cell-cell adhesion.
2010-11-18 GO:0072370 histone H2A-S121 phosphorylation Added TERM histone H2A-S121 phosphorylation
2010-11-18 GO:0072371 histone kinase activity (H2A-S121 specific) Added TERM histone kinase activity (H2A-S121 specific)
2010-11-18 GO:2000250 negative regulation of actin cytoskeleton reorganization Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of actin cytoskeleton reorganization.
2010-11-18 GO:0002207 gene conversion of immunoglobulin genes involved in immune response Added DEFINITION The somatic process in which immunoglobulin genes are diversified through the mechanism of gene conversion following the induction of and contributing to an immune response.
2010-11-18 GO:0002365 gamma-delta T cell lineage commitment Added DEFINITION The process in which a pro-T cell becomes committed to becoming a gamma-delta T cell.
2010-11-18 GO:2000162 negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of planar cell polarity pathway involved in cardiac right atrium morphogenesis.
2010-11-18 GO:2000173 negative regulation of branching morphogenesis of a nerve Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of branching morphogenesis of a nerve.
2010-11-18 GO:0002428 antigen processing and presentation of peptide antigen via MHC class Ib Added DEFINITION The process in which an antigen-presenting cell expresses peptide antigen in association with an MHC class Ib protein complex on its cell surface. The peptide antigen may originate from an endogenous or exogenous protein. Class Ib here refers to non-classical class I molecules, such as those of the HLA-E family.
2010-11-18 GO:0002481 antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent Added DEFINITION The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class Ib protein complex following intracellular transport via a TAP (transporter associated with antigen processing) pathway. The peptide is typically a fragment of a larger exogenous protein which has been degraded within the cell and is dependent on TAP transport from the cytosol to ER for association with the MHC class Ib molecule. Class Ib here refers to non-classical class I molecules, such as those of the HLA-E gene family.
2010-11-18 GO:0003065 positive regulation of heart rate by epinephrine Added DEFINITION The process in which the secretion of epinephrine into the bloodstream or released from nerve endings increases the rate of heart muscle contraction.
2010-11-18 GO:0003066 positive regulation of heart rate by norepinephrine Added DEFINITION The process in which the secretion of norepinephrine into the bloodstream or released from nerve endings increases the rate of heart muscle contraction.
2010-11-18 GO:0003067 circadian regulation of systemic arterial blood pressure by hormone Added DEFINITION The process in which hormones modulate the force with which blood passes through the circulatory system contributing to different values of blood pressure oscillating with a regularity of approximately 24 hours. A hormone is one of a group of substances formed in very small amounts in one specialized organ or group of cells and carried (sometimes in the bloodstream) to another organ or group of cells, in the same organism, upon which they have a specific regulatory action.
2010-11-18 GO:0003087 positive regulation of the force of heart contraction by neuronal epinephrine Added DEFINITION The process in which the release of epinephrine from nerve endings modulates the force of heart muscle contraction.
2010-11-18 GO:0003088 positive regulation of the force of heart contraction by circulating epinephrine Added DEFINITION The process in which the secretion of epinephrine into the bloodstream modulates the force of heart muscle contraction.
2010-11-18 GO:0003142 cardiogenic plate morphogenesis Added DEFINITION The process in which the anatomical structures of the cardiogenic plate are generated and organized. The cardiogenic plate is the first recognizable structure derived from the heart field.
2010-11-18 GO:0033624 negative regulation of integrin activation Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate, or extent of integrin activation.
2010-11-18 GO:0072369 regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter Added DEFINITION Any process that modulates the frequency, rate or extent of lipid transport by activating or increasing the frequency, rate or extent of transcription from an RNA polymerase II promoter.
2010-11-18 GO:0072371 histone kinase activity (H2A-S121 specific) Added DEFINITION Catalysis of the transfer of a phosphate group to the serine-121 residue of the N-terminal tail of histone H2A.
2010-11-18 GO:2000157 negative regulation of ubiquitin-specific protease activity Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of ubiquitin-specific protease activity.
2010-11-18 GO:2000183 negative regulation of progesterone biosynthetic process Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of progesterone biosynthetic process.
2010-11-18 GO:2000204 negative regulation of ribosomal large subunit export from nucleus Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of ribosomal large subunit export from nucleus.
2010-11-18 GO:2000227 negative regulation of pancreatic A cell differentiation Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of pancreatic A cell differentiation.
2010-11-18 GO:0018220 peptidyl-threonine palmitoylation Deleted DEFINITION The palmitoylation of peptidyl-threonine to form peptidyl-O-palmitoyl-L-threonine.
2010-11-18 GO:0034104 negative regulation of tissue remodeling Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate, or extent of tissue remodeling.
2010-11-18 GO:0002428 antigen processing and presentation of peptide antigen via MHC class Ib Deleted DEFINITION The process by which an antigen-presenting cell expresses peptide antigen in association with an MHC class Ib protein complex on its cell surface. The peptide antigen may originate from an endogenous or exogenous protein. Class Ib here refers to non-classical class I molecules, such as those of the HLA-E family.
2010-11-18 GO:2000248 negative regulation of establishment or maintenance of neuroblast polarity Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of establishment or maintenance of neuroblast polarity.
2010-11-18 GO:0002468 dendritic cell antigen processing and presentation Deleted DEFINITION The process by which a dendritic cell expresses antigen (peptide or lipid) on its cell surface in association with an MHC protein complex.
2010-11-18 GO:2000195 negative regulation of female gonad development Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of female gonad development.
2010-11-18 GO:0003128 heart field specification Deleted DEFINITION The process by which a specific region of the lateral mesoderm is delineated into the area in which the heart will develop.
2010-11-18 GO:2000175 negative regulation of pro-T cell differentiation Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of pro-T cell differentiation.
2010-11-18 GO:0002563 somatic diversification of immune receptors via alternate splicing Deleted DEFINITION The process by which immune receptor genes are diversified through alternate splicing.
2010-11-18 GO:0021764 amygdala development Deleted DEFINITION The progression of the amygdala over time from its initial formation until its mature state. The amygdala is an almond shaped set of neurons in the medial temporal lobe of the brain that play a key role in processing emotions such as fear and pleasure.
2010-11-18 GO:0002479 antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent Deleted DEFINITION The process by which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class I protein complex following intracellular transport via a TAP (transporter associated with antigen processing) pathway. The peptide is typically a fragment of a larger exogenous protein which has been degraded within the cell and is dependent on TAP transport from the cytosol to ER for association with the MHC class I molecule. Class I here refers to classical class I molecules.
2010-11-18 GO:0003039 detection of reduced oxygen by carotid body chemoreceptor signaling Deleted DEFINITION The process by which information about the levels of oxygen are received and are converted to a molecular signal by chemoreceptors in a carotid body.
2010-11-18 GO:0002450 B cell antigen processing and presentation Deleted DEFINITION The process by which a B cell expresses antigen (peptide or lipid) on its cell surface in association with an MHC protein complex.
2010-11-18 GO:0003054 circadian regulation of systemic arterial blood pressure by the suprachiasmatic nucleus Deleted DEFINITION The process by which the suprachiasmatic nucleus modulates blood pressure at different values with a regularity of approximately 24 hours.
2010-11-18 GO:0002204 somatic recombination of immunoglobulin genes involved in immune response Deleted DEFINITION The process by which immunoglobulin genes are formed through recombination of the germline genetic elements, also known as immunoglobulin gene segments, within a single locus following the induction of and contributing to an immune response.
2010-11-18 GO:0002175 protein localization to paranode region of axon Deleted DEFINITION Any process by which a protein is transported to, or maintained at, the paranode region of an axon.
2010-11-18 GO:0003052 circadian regulation of systemic arterial blood pressure Deleted DEFINITION Any process by which an organism modulates its blood pressure at different values with a regularity of approximately 24 hours.
2010-11-18 GO:0002475 antigen processing and presentation via MHC class Ib Deleted DEFINITION The process by which an antigen-presenting cell expresses antigen (peptide or lipid) on its cell surface in association with an MHC class Ib protein complex. Class Ib here refers to non-classical class I molecules, such as those of the CD1 or HLA-E gene families.
2010-11-18 GO:0003112 positive regulation of heart rate by neuronal epinephrine Added DEFINITION The process in which the secretion of epinephrine from nerve endings increases the rate of heart muscle contraction.
2010-11-18 GO:0003138 primary heart field specification Added DEFINITION The process that results in the deliniation of a specific region of the lateral mesoderm into the area which will form the primary beating heart tube.
2010-11-18 GO:0018009 N-terminal peptidyl-L-cysteine N-palmitoylation Added DEFINITION The covalent attachment of a palmitoyl group to a nitrogen (N) atom in an N-terminal cysteine residue to form N-palmitoyl-L-cysteine.
2010-11-18 GO:0033633 negative regulation of cell-cell adhesion mediated by integrin Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate, or extent of cell-cell adhesion mediated by integrin.
2010-11-18 GO:0034115 negative regulation of heterotypic cell-cell adhesion Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate, or extent of heterotypic cell-cell adhesion.
2010-11-18 GO:0072363 regulation of glycolytic by positive regulation of transcription from RNA polymerase II promoter Added DEFINITION Any process that modulates the frequency, rate or extent of glycolysis by activating or increasing the frequency, rate or extent of transcription from an RNA polymerase II promoter.
2010-11-18 GO:0072368 regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter Added DEFINITION Any process that modulates the frequency, rate or extent of lipid transport by stopping, preventing, or reducing the frequency, rate or extent of transcription from an RNA polymerase II promoter.
2010-11-18 GO:2000164 negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of planar cell polarity pathway involved in outflow tract morphogenesis.
2010-11-18 GO:2000198 negative regulation of ribonucleoprotein complex localization Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of ribonucleoprotein complex localization.
2010-11-18 GO:2000239 negative regulation of tRNA export from nucleus Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of tRNA export from nucleus.
2010-11-18 GO:0002566 somatic diversification of immune receptors via somatic mutation Added DEFINITION The process in which immune receptor genes are diversified through somatic mutation.
2010-11-18 GO:0003004 follicular fluid formation in ovarian follicle antrum involved in distinct antral spaces stage Added DEFINITION The menstrual cycle process in which one central cavity separating the oocyte/cumulus complex from mural granulosa and theca cells is formed as part of the antral spaces stage of oogenesis.
2010-11-18 GO:0003007 heart morphogenesis Added DEFINITION The developmental process in which the heart is generated and organized. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood.
2010-11-18 GO:0003034 detection of increased carbon dioxide by aortic body chemoreceptor signaling Added DEFINITION The process in which information about the levels of carbon dioxideare received and are converted to a molecular signal by chemoreceptors in an aortic body.
2010-11-18 GO:0003036 detection of pH by aortic body chemoreceptor signaling Added DEFINITION The process in which information about the levels of hydrogen ions are received and are converted to a molecular signal by chemoreceptors in an aortic body.
2010-11-18 GO:0003037 detection of pH by carotid body chemoreceptor signaling Added DEFINITION The process in which information about the levels of hydrogen ions are received and are converted to a molecular signal by chemoreceptors in a carotid body.
2010-11-18 GO:0003081 regulation of systemic arterial blood pressure by renin-angiotensin Added DEFINITION The process in which renin-angiotensin modulates the force with which blood passes through the circulatory system.
2010-11-18 GO:0003082 positive regulation of renal output by angiotensin Added DEFINITION Any process in which angiotensin directly increases the rate of natriuresis and diuresis in the kidney.
2010-11-18 GO:0001944 vasculature development Deleted DEFINITION The process whose specific outcome is the progression of the vasculature over time, from its formation to the mature structure.
2010-11-18 GO:0003098 tubuloglomerular feedback Deleted DEFINITION The process by which blood volume is regulated due to a change in the rate of glomerular filtration. This is accomplished by a feedback mechanism that senses changes in the juxtaglomerular apparatus.
2010-11-18 GO:2000198 negative regulation of ribonucleoprotein complex localization Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of ribonucleoprotein complex localization.
2010-11-18 GO:0002362 CD4-positive, CD25-positive, alpha-beta regulatory T cell lineage commitment Deleted DEFINITION The process by which a CD4-positive, alpha-beta T cell becomes committed to becoming a CD4-positive, CD25-positive, alpha-beta regulatory T cell.
2010-11-18 GO:0046918 N-terminal peptidyl-glycine N-palmitoylation Deleted DEFINITION The palmitoylation of the N-terminal glycine of proteins to form the derivative N-palmitoyl-glycine.
2010-11-18 GO:0003138 primary heart field specification Deleted DEFINITION The process by which a specific region of the lateral mesoderm is delineated into the area which will form the primary beating heart tube.
2010-11-18 GO:0002204 somatic recombination of immunoglobulin genes involved in immune response Added DEFINITION The process in which immunoglobulin genes are formed through recombination of the germline genetic elements, also known as immunoglobulin gene segments, within a single locus following the induction of and contributing to an immune response.
2010-11-18 GO:0002208 somatic diversification of immunoglobulins involved in immune response Added DEFINITION The somatic process that results in the generation of sequence diversity of immunoglobulins after induction, and contributes to an immune response.
2010-11-18 GO:0002350 peripheral B cell positive selection Added DEFINITION Any process leading to positive selection of B cells in the periphery. Positive selection is the process in which B or T cells are selected to survive based on signaling through their antigen receptors.
2010-11-18 GO:0002476 antigen processing and presentation of endogenous peptide antigen via MHC class Ib Added DEFINITION The process in which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC class Ib protein complex. The peptide is typically a fragment of a larger endogenous protein which has been degraded within the cell. Class Ib here refers to non-classical class I molecules, such as those of the HLA-E gene family.
2010-11-18 GO:0002485 antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent Added DEFINITION The process in which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC class I protein complex following intracellular transport via a TAP-dependent ER pathway. The peptide is typically a fragment of a larger endogenous protein which has been degraded within the cell and becomes associated with the MHC class I molecule in the ER following TAP-dependent transport from the cytosol. Class I here refers to classical class I molecules.
2010-11-18 GO:2000180 negative regulation of androgen biosynthetic process Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of androgen biosynthetic process.
2010-11-18 GO:2000157 negative regulation of ubiquitin-specific protease activity Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of ubiquitin-specific protease activity.
2010-11-18 GO:0003065 positive regulation of heart rate by epinephrine Deleted DEFINITION The process by which the secretion of epinephrine into the bloodstream or released from nerve endings increases the rate of heart muscle contraction.
2010-11-18 GO:0002546 negative regulation of tissue kallikrein-kinin cascade Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate, or extent of the tissue kallikrein-kinin cascade.
2010-11-18 GO:0003111 positive regulation of heart rate by circulating epinephrine Deleted DEFINITION The process by which the secretion of epinephrine into the bloodstream increases the rate of heart muscle contraction.
2010-11-18 GO:0002568 somatic diversification of T cell receptor genes Deleted DEFINITION The somatic process by means of which sequence diversity of T cell receptor genes is generated.
2010-11-18 GO:2000162 negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of planar cell polarity pathway involved in cardiac right atrium morphogenesis.
2010-11-18 GO:0003061 positive regulation of the force of heart contraction by norepinephrine Deleted DEFINITION The process by which the secretion of norepinephrine into the bloodstream or released from nerve endings modulates the force of heart musclecontraction.
2010-11-18 GO:0003159 morphogenesis of an endothelium Deleted DEFINITION The process by which the anatomical structure of an endothelium is generated and organized. An endothelium is an epithelium that lines an anatomical structure.
2010-11-18 GO:2000204 negative regulation of ribosomal large subunit export from nucleus Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of ribosomal large subunit export from nucleus.
2010-11-18 GO:0002488 antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway Deleted DEFINITION The process by which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC class Ib protein complex following intracellular transport via an ER pathway. The peptide is typically a fragment of a larger endogenous protein which has been degraded within the cell and becomes associated with the MHC class Ib molecule in the ER. Class Ib here refers to non-classical class I molecules, such as those of the HLA-E gene family.
2010-11-18 GO:2000201 negative regulation of ribosomal subunit export from nucleus Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of ribosomal subunit export from nucleus.
2010-11-18 GO:0002565 somatic diversification of immune receptors via gene conversion Deleted DEFINITION The process by which immune receptor genes are diversified through gene conversion.
2010-11-18 GO:0003081 regulation of systemic arterial blood pressure by renin-angiotensin Deleted DEFINITION The process by which renin-angiotensin modulates the force with which blood passes through the circulatory system.
2010-11-18 GO:0010362 negative regulation of anion channel activity by blue light Deleted DEFINITION Any process by which the blue light stops, prevents or reduces the frequency, rate, or extent of the anion channel activity.
2010-11-18 GO:0002257 negative regulation of kinin cascade Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate, or extent of the kinin cascade.
2010-11-18 GO:0003112 positive regulation of heart rate by neuronal epinephrine Deleted DEFINITION The process by which the secretion of epinephrine from nerve endings increases the rate of heart muscle contraction.
2010-11-18 GO:0002489 antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent Deleted DEFINITION The process by which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC class Ib protein complex following intracellular transport via a TAP (transporter associated with antigen processing) pathway. The peptide is typically a fragment of a larger endogenous protein which has been degraded within the cell and is dependent on TAP transport from the cytosol to ER for association with the MHC class Ib molecule. Class Ib here refers to non-classical class I molecules, such as those of the HLA-E gene family.
2010-11-18 GO:0003109 positive regulation of the force of heart contraction by circulating norepinephrine Deleted DEFINITION The process by which the secretion of norepinephrine into the bloodstream modulates the force of heart muscle contraction.
2010-11-18 GO:0003038 detection of reduced oxygen by aortic body chemoreceptor signaling Deleted DEFINITION The process by which information about the levels of oxygen are received and are converted to a molecular signal by chemoreceptors in an aortic body.
2010-11-18 GO:2000207 negative regulation of ribosomal small subunit export from nucleus Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of ribosomal small subunit export from nucleus.
2010-11-18 GO:0003143 embryonic heart tube morphogenesis Deleted DEFINITION The process by which the anatomical structures of the embryonic heart tube are generated and organized. Morphogenesis pertains to the creation of form. The embryonic heart tube is an epithelial tube that will give rise to the mature heart.
2010-11-18 GO:0003001 generation of a signal involved in cell-cell signaling Deleted DEFINITION The cellular process by which a physical entity or change in state, a signal, is created that originates in one cell and is used to transfer information to another cell. This process begins with the initial formation of the signal and ends with the mature form and placement of the signal.
2010-11-18 GO:0003106 negative regulation of glomerular filtration by angiotensin Deleted DEFINITION The process by which angiotensin directly decreases the rate of glomerular filtration in the kidney. Glomerular filtration is the processs whereby blood is filtered by the glomerulus into the renal tubule.
2010-11-18 GO:0002486 antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent Deleted DEFINITION The process by which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC class I protein complex following intracellular transport via a TAP-independent ER pathway. The peptide is typically a fragment of a larger endogenous protein which has been degraded within the cell and becomes associated with the MHC class I molecule in the ER following transport from the cytosol via a TAP-independent pathway. Class I here refers to classical class I molecules.
2010-11-18 GO:2000168 negative regulation of planar cell polarity pathway involved in neural tube closure Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of planar cell polarity pathway involved in neural tube closure.
2010-11-18 GO:2000239 negative regulation of tRNA export from nucleus Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of tRNA export from nucleus.
2010-11-18 GO:0003006 developmental process involved in reproduction Deleted DEFINITION A developmental process by which a progressive change in the state of some part of an organism specifically contributes to its ability to form offspring.
2010-11-18 GO:0002471 monocyte antigen processing and presentation Deleted DEFINITION The process by which a monocyte expresses antigen (peptide or lipid) on its cell surface in association with an MHC protein complex.
2010-11-18 GO:0033004 negative regulation of mast cell activation Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate, or extent of mast cell activation.
2010-11-18 GO:2000154 negative regulation of flagellar cell motility Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of flagellar cell motility.
2010-11-18 GO:0002350 peripheral B cell positive selection Deleted DEFINITION Any process leading to positive selection of B cells in the periphery. Positive selection is the process by which B or T cells are selected to survive based on signaling through their antigen receptors.
2010-11-18 GO:0017014 protein nitrosylation Deleted DEFINITION The addition of a nitrosyl group to a protein amino acid.
2010-11-18 GO:2000242 negative regulation of reproductive process Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of reproductive process.
2010-11-18 GO:0002477 antigen processing and presentation of exogenous peptide antigen via MHC class Ib Deleted DEFINITION The process by which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class Ib protein complex. The peptide is typically a fragment of a larger exogenous protein which has been degraded within the cell. Class Ib here refers to non-classical class I molecules, such as those of the HLA-E gene family.
2010-11-18 GO:0061369 negative regulation of testicular blood vessel morphogenesis Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of blood vessel morphogenesis in the testicle.
2010-11-18 GO:0003064 regulation of heart rate by hormone Deleted DEFINITION The process by which the hormones modulates the rate of heart muscle contraction. A hormone is one of a group of substances formed in very small amounts in one specialized organ or group of cells and carried (sometimes in the bloodstream) to another organ or group of cells, in the same organism, upon which they have a specific regulatory action.
2010-11-18 GO:0003022 detection of pH by chemoreceptor signaling Deleted DEFINITION The process by which information about the levels of hydrogen ions are received and are converted to a molecular signal by chemoreceptors in the carotid bodies and the aortic bodies.
2010-11-18 GO:0003067 circadian regulation of systemic arterial blood pressure by hormone Deleted DEFINITION The process by which hormones modulate the force with which blood passes through the circulatory system contributing to different values of blood pressure oscillating with a regularity of approximately 24 hours. A hormone is one of a group of substances formed in very small amounts in one specialized organ or group of cells and carried (sometimes in the bloodstream) to another organ or group of cells, in the same organism, upon which they have a specific regulatory action.
2010-11-18 GO:0003095 pressure natriuresis Deleted DEFINITION The process by which the volume of blood increases renal pressure and results in an increase in natriuresis and diuresis.
2010-11-18 GO:0002472 macrophage antigen processing and presentation Deleted DEFINITION The process by which a macrophage expresses antigen (peptide or lipid) on its cell surface in association with an MHC protein complex.
2010-11-18 GO:0003041 excitation of vasomotor center by carotid body chemoreceptor signaling Deleted DEFINITION The process by which the molecular signal from a carotid body is relayed to the vasomotor center, causing it to signal an increase arterial pressure.
2010-11-18 GO:0002562 somatic diversification of immune receptors via germline recombination within a single locus Deleted DEFINITION The process by which immune receptor genes are diversified through recombination of the germline genetic elements within a single genetic locus.
2010-11-18 GO:0003142 cardiogenic plate morphogenesis Deleted DEFINITION The process by which the anatomical structures of the cardiogenic plate are generated and organized. The cardiogenic plate is the first recognizable structure derived from the heart field.
2010-11-18 GO:2000250 negative regulation of actin cytoskeleton reorganization Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of actin cytoskeleton reorganization.
2010-11-18 GO:0003151 outflow tract morphogenesis Deleted DEFINITION The process by which the anatomical structures of the outflow tract are generated and organized. Morphogenesis pertains to the creation of form. The outflow tract is the portion of the heart through which blood flows into the arteries.
2010-11-18 GO:0002480 antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent Deleted DEFINITION The process by which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class I protein complex following intracellular transport via a pathway not requiring TAP (transporter associated with antigen processing). The peptide is typically a fragment of a larger exogenous protein which has been degraded within the cell. Class I here refers to classical class I molecules.
2010-11-18 GO:2000225 negative regulation of testosterone biosynthetic process Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of testosterone biosynthetic process.
2010-11-18 GO:0002470 plasmacytoid dendritic cell antigen processing and presentation Deleted DEFINITION The process by which a plasmacytoid dendritic cell expresses antigen (peptide or lipid) on its cell surface in association with an MHC protein complex.
2010-11-18 GO:0002566 somatic diversification of immune receptors via somatic mutation Deleted DEFINITION The process by which immune receptor genes are diversified through somatic mutation.
2010-11-18 GO:0003082 positive regulation of renal output by angiotensin Deleted DEFINITION Any process by which angiotensin directly increases the rate of natriuresis and diuresis in the kidney.
2010-11-18 GO:2000190 negative regulation of regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor.
2010-11-18 GO:0002365 gamma-delta T cell lineage commitment Deleted DEFINITION The process by which a pro-T cell becomes committed to becoming a gamma-delta T cell.
2010-11-18 GO:0002346 B cell positive selection Deleted DEFINITION Any process by which B cells are selected to survive based on signaling through the B cell antigen receptor.
2010-11-18 GO:0003021 detection of increased carbon dioxide by chemoreceptor signaling Deleted DEFINITION The process by which information about the levels of carbon dioxideare received and are converted to a molecular signal by chemoreceptors in the carotid bodies and the aortic bodies.
2010-11-18 GO:0002363 alpha-beta T cell lineage commitment Deleted DEFINITION The process by which a pro-T cell becomes committed to becoming an alpha-beta T cell.
2010-11-18 GO:0018119 peptidyl-cysteine S-nitrosylation Deleted DEFINITION The S-nitrosylation of peptidyl-cysteine to form peptidyl-S-nitrosyl-L-cysteine.
2010-11-18 GO:2000227 negative regulation of pancreatic A cell differentiation Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of pancreatic A cell differentiation.
2010-11-18 GO:2000151 negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis.
2010-11-18 GO:0035606 peptidyl-cysteine S-trans-nitrosylation Added DEFINITION Transfer of a nitric oxide (NO) group from one cysteine residue to another.
2010-11-18 GO:0043371 negative regulation of CD4-positive, alpha-beta T cell differentiation Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate, or extent of CD4-positive, alpha beta T cell differentiation.
2010-11-18 GO:0072358 cardiovascular system development Added DEFINITION The process whose specific outcome is the progression of the cardiovascular system over time, from its formation to the mature structure. The cardiovascular system is the anatomical system that has as its parts the heart and blood vessels.
2010-11-18 GO:0072364 regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter Added DEFINITION Any process that modulates the frequency, rate or extent of a cellular ketone metabolic process by modulating the frequency, rate or extent of transcription from an RNA polymerase II promoter.
2010-11-18 GO:0072367 regulation of lipid transport by regulation of transcription from RNA polymerase II promoter Added DEFINITION Any process that modulates the frequency, rate or extent of lipid transport by modulating the frequency, rate or extent of transcription from an RNA polymerase II promoter.
2010-11-18 GO:2000186 negative regulation of phosphate transmembrane transport Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of phosphate transmembrane transport.
2010-11-18 GO:0018230 peptidyl-L-cysteine S-palmitoylation Deleted DEFINITION The palmitoylation of peptidyl-serine to form peptidyl-S-palmitoyl-L-cysteine; the palmitate group represents a mixture of saturated and unsaturated fatty acids.
2010-11-18 GO:0016445 somatic diversification of immunoglobulins Deleted DEFINITION The somatic process by means of which sequence diversity of immunoglobulins is generated.
2010-11-18 GO:0003066 positive regulation of heart rate by norepinephrine Deleted DEFINITION The process by which the secretion of norepinephrine into the bloodstream or released from nerve endings increases the rate of heart muscle contraction.
2010-11-18 GO:0002680 pro-T cell lineage commitment Deleted DEFINITION The process by which a lymphoid progenitor cell becomes committed to becoming a pro-T cell.
2010-11-18 GO:0003160 endocardium morphogenesis Deleted DEFINITION The process by which the anatomical structure of the endocardium is generated and organized. The endocardium is an anatomical structure comprised of an endothelium and an extracellular matrix that forms the innermost layer of tissue of the heart, and lines the heart chambers.
2010-11-18 GO:0002469 myeloid dendritic cell antigen processing and presentation Deleted DEFINITION The process by which a myeloid dendritic cell expresses antigen (peptide or lipid) on its cell surface in association with an MHC protein complex.
2010-11-18 GO:0002344 B cell affinity maturation Deleted DEFINITION The process by which B cells produce antibodies with increased antigen affinity. This is accomplished by somatic hypermutation and selection for B cells which produce higher affinity antibodies to antigen.
2010-11-18 GO:0002487 antigen processing and presentation of endogenous peptide antigen via MHC class I via endolysosomal pathway Deleted DEFINITION The process by which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC class I protein complex. The peptide is typically a fragment of a larger endogenous protein which has been degraded within the cell and becomes associated with the MHC class I molecule in an endolysosome. Class I here refers to classical class I molecules.
2010-11-18 GO:0002476 antigen processing and presentation of endogenous peptide antigen via MHC class Ib Deleted DEFINITION The process by which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC class Ib protein complex. The peptide is typically a fragment of a larger endogenous protein which has been degraded within the cell. Class Ib here refers to non-classical class I molecules, such as those of the HLA-E gene family.
2010-11-18 GO:0003114 positive regulation of heart rate by circulating norepinephrine Deleted DEFINITION The process by which the secretion of norepinephrine into the bloodstream increases the rate of heart muscle contraction.
2010-11-18 GO:2000166 negative regulation of planar cell polarity pathway involved in pericardium morphogenesis Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of planar cell polarity pathway involved in pericardium morphogenesis.
2010-11-18 GO:2000181 negative regulation of blood vessel morphogenesis Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of blood vessel morphogenesis.
2010-11-18 GO:0003113 positive regulation of heart rate by neuronal norepinephrine Deleted DEFINITION The process by which the secretion of norepinephrine released from nerve endings increases the rate of heart muscle contraction.
2010-11-18 GO:0002549 negative regulation of plasma kallikrein-kinin cascade Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate, or extent of the plasma kallikrein-kinin cascade.
2010-11-18 GO:0034119 negative regulation of erythrocyte aggregation Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate, or extent of erythrocyte aggregation.
2010-11-18 GO:0002207 gene conversion of immunoglobulin genes involved in immune response Deleted DEFINITION The somatic process by which immunoglobulin genes are diversified through the mechanism of gene conversion following the induction of and contributing to an immune response.
2010-11-18 GO:2000233 negative regulation of rRNA processing Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of rRNA processing.
2010-11-18 GO:2000215 negative regulation of proline metabolic process Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of proline metabolic process.
2010-11-18 GO:2000171 negative regulation of dendrite development Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of dendrite development.
2010-11-18 GO:0003007 heart morphogenesis Deleted DEFINITION The developmental process by which the heart is generated and organized. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood.
2010-11-18 GO:0003004 follicular fluid formation in ovarian follicle antrum involved in distinct antral spaces stage Deleted DEFINITION The menstrual cycle process by which one central cavity separating the oocyte/cumulus complex from mural granulosa and theca cells is formed as part of the antral spaces stage of oogenesis.
2010-11-18 GO:2000149 negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of planar cell polarity pathway involved in ventricular septum morphogenesis.
2010-11-18 GO:0003101 regulation of systemic arterial blood pressure by circulatory epinephrine-norepinephrine Deleted DEFINITION The process by which epinephrine-norepinephrine modulate the force with which blood passes through the circulatory system.
2010-11-18 GO:0002360 T cell lineage commitment Deleted DEFINITION The process by which a lymphoid progenitor cell becomes committed to becoming any type of T cell.
2010-11-18 GO:0003036 detection of pH by aortic body chemoreceptor signaling Deleted DEFINITION The process by which information about the levels of hydrogen ions are received and are converted to a molecular signal by chemoreceptors in an aortic body.
2010-11-18 GO:0003003 follicular fluid formation in ovarian follicle antrum involved in fused antrum stage Deleted DEFINITION The ovulation cycle process by which one central cavity separating the oocyte/cumulus complex from mural granulosa and theca cells is formed as part of the fused antrum stage of oogenesis.
2010-11-18 GO:0003035 detection of increased carbon dioxide by carotid body chemoreceptor signaling Deleted DEFINITION The process by which information about the levels of carbon dioxideare received and are converted to a molecular signal by chemoreceptors in a carotid body.
2010-11-18 GO:0003107 positive regulation of natriuresis by angiotensin Deleted DEFINITION The process by which angiotensin increases the rate of natriuresis indirectly via diuresis. Natriuresis is the process of renal sodium excretion.
2010-11-18 GO:0003100 regulation of systemic arterial blood pressure by endothelin Deleted DEFINITION The process by which endothelin modulates the force with which blood passes through the circulatory system. Endothelin is a hormone that is released by the endothelium, and it is a vasoconstrictor.
2010-11-18 GO:0033629 negative regulation of cell adhesion mediated by integrin Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate, or extent of cell adhesion mediated by integrin.
2010-11-18 GO:0002681 somatic recombination of T cell receptor gene segments Deleted DEFINITION The process by which T cell receptor genes are formed through recombination of the germline genetic elements, also known as T cell receptor gene segments.
2010-11-18 GO:0002206 gene conversion of immunoglobulin genes Deleted DEFINITION The somatic process by which immunoglobulin genes are diversified through the mechanism of gene conversion.
2010-11-18 GO:0002491 antigen processing and presentation of endogenous peptide antigen via MHC class II Deleted DEFINITION The process by which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC class II protein complex. The peptide antigen is typically, but not always, processed from a whole protein.
2010-11-18 GO:0002348 central B cell positive selection Deleted DEFINITION Any process leading to positive selection of B cells in the bone marrow. Positive selection is the process by which B or T cells are selected to survive based on signaling through their antigen receptors.
2010-11-18 GO:2000212 negative regulation of glutamate metabolic process Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of glutamate metabolic process.
2010-11-18 GO:0000769 syncytium formation by mitosis without cytokinesis Deleted DEFINITION The formation of a syncytium, a mass of cytoplasm containing several nuclei enclosed within a single plasma membrane, by one or more rounds of nuclear division without cell division.
2010-11-18 GO:0002474 antigen processing and presentation of peptide antigen via MHC class I Deleted DEFINITION The process by which an antigen-presenting cell expresses a peptide antigen on its cell surface in association with an MHC class I protein complex. Class I here refers to classical class I molecules.
2010-11-18 GO:0002495 antigen processing and presentation of peptide antigen via MHC class II Deleted DEFINITION The process by which an antigen-presenting cell expresses a peptide antigen on its cell surface in association with an MHC class II protein complex. The peptide antigen is typically, but not always, processed from a whole protein.
2010-11-18 GO:0002482 antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-independent Deleted DEFINITION The process by which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class Ib protein complex following intracellular transport via a pathway not requiring TAP (transporter associated with antigen processing). The peptide is typically a fragment of a larger exogenous protein which has been degraded within the cell. Class Ib here refers to non-classical class I molecules, such as those of the HLA-E gene family.
2010-11-18 GO:2000245 negative regulation of FtsZ-dependent cytokinesis Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of cytokinesis by binary fission.
2010-11-18 GO:0002336 B-1 B cell lineage commitment Deleted DEFINITION The process by which an immature B cell becomes committed to become a B-1 B cell.
2010-11-18 GO:0000769 syncytium formation by mitosis without cytokinesis Added DEFINITION The formation of a syncytium, a mass of cytoplasm containing several nuclei enclosed within a single plasma membrane, by one or more rounds of nuclear division without cytokinesis.
2010-11-18 GO:0001945 lymph vessel development Added DEFINITION The process whose specific outcome is the progression of a lymph vessel over time, from its formation to the mature structure.
2010-11-18 GO:0002257 negative regulation of kinin cascade Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate, or extent of the kinin cascade.
2010-11-18 GO:0002467 germinal center formation Added DEFINITION The process in which germinal centers form. A germinal center is a specialized microenvironment formed when activated B cells enter lymphoid follicles. Germinal centers are the foci for B cell proliferation and somatic hypermutation.
2010-11-18 GO:0002474 antigen processing and presentation of peptide antigen via MHC class I Added DEFINITION The process in which an antigen-presenting cell expresses a peptide antigen on its cell surface in association with an MHC class I protein complex. Class I here refers to classical class I molecules.
2010-11-18 GO:0002477 antigen processing and presentation of exogenous peptide antigen via MHC class Ib Added DEFINITION The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class Ib protein complex. The peptide is typically a fragment of a larger exogenous protein which has been degraded within the cell. Class Ib here refers to non-classical class I molecules, such as those of the HLA-E gene family.
2010-11-18 GO:0002479 antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent Added DEFINITION The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class I protein complex following intracellular transport via a TAP (transporter associated with antigen processing) pathway. The peptide is typically a fragment of a larger exogenous protein which has been degraded within the cell and is dependent on TAP transport from the cytosol to ER for association with the MHC class I molecule. Class I here refers to classical class I molecules.
2010-11-18 GO:0002482 antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-independent Added DEFINITION The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class Ib protein complex following intracellular transport via a pathway not requiring TAP (transporter associated with antigen processing). The peptide is typically a fragment of a larger exogenous protein which has been degraded within the cell. Class Ib here refers to non-classical class I molecules, such as those of the HLA-E gene family.
2010-11-18 GO:0002483 antigen processing and presentation of endogenous peptide antigen Added DEFINITION The process in which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC protein complex. The peptide is typically a fragment of a larger endogenous protein which has been degraded within the cell.
2010-11-18 GO:0002546 negative regulation of tissue kallikrein-kinin cascade Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate, or extent of the tissue kallikrein-kinin cascade.
2010-11-18 GO:0002568 somatic diversification of T cell receptor genes Added DEFINITION The somatic process that results in the generation of sequence diversity of T cell receptor genes.
2010-11-18 GO:0061369 negative regulation of testicular blood vessel morphogenesis Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of blood vessel morphogenesis in the testicle.
2010-11-18 GO:0072360 vascular cord development Added DEFINITION The progression of the vascular cord over time from its initial formation until its mature state. The vascular cord is the primordial vasculature that will develop into blood vessels by the process of tubulogenesis.
2010-11-18 GO:0072361 regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter Added DEFINITION Any process that modulates the frequency, rate or extent of glycolysis by modulating the frequency, rate or extent of transcription from an RNA polymerase II promoter.
2010-11-18 GO:0072366 regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter Added DEFINITION Any process that modulates the frequency, rate or extent of a cellular ketone metabolic process by activating or increasing the frequency, rate or extent of transcription from an RNA polymerase II promoter.
2010-11-18 GO:0072370 histone H2A-S121 phosphorylation Added DEFINITION The modification of histone H2A by the addition of an phosphate group to a serine residue at position 121 of the histone.
2010-11-18 GO:2000160 negative regulation of planar cell polarity pathway involved in heart morphogenesis Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of planar cell polarity pathway involved in heart morphogenesis.
2010-11-18 GO:0003152 morphogenesis of an epithelial fold involved in embryonic heart tube formation Deleted DEFINITION The morphogenetic process by which an epithelial sheet bends along a linear axis that contributes to embryonic heart tube formation.
2010-11-18 GO:2000146 negative regulation of cell motility Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of cell motility.
2010-11-18 GO:0003019 central nervous system control of baroreceptor feedback Deleted DEFINITION The neurological process by which nerve impulses arising in the aorta or the carotid sinuses travel to the medulla and reach the nucleus of tractus solaris.
2010-11-18 GO:2000221 negative regulation of pseudohyphal growth Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of pseudohyphal growth.
2010-11-18 GO:0003059 positive regulation of the force of heart contraction by epinephrine Deleted DEFINITION The process by which the secretion of epinephrine into the bloodstream or released from nerve endings modulates the force of heart muscle contraction.
2010-11-18 GO:0002472 macrophage antigen processing and presentation Added DEFINITION The process in which a macrophage expresses antigen (peptide or lipid) on its cell surface in association with an MHC protein complex.
2010-11-18 GO:0002473 non-professional antigen presenting cell antigen processing and presentation Added DEFINITION The process in which a non-professional antigen presenting cell expresses antigen (peptide or lipid) on its cell surface in association with an MHC protein complex. Non-professional antigen presenting cells include all cell types but dendritic cells, B cells, T cells, monocytes, macrophages, and neutrophils.
2010-11-18 GO:0002475 antigen processing and presentation via MHC class Ib Added DEFINITION The process in which an antigen-presenting cell expresses antigen (peptide or lipid) on its cell surface in association with an MHC class Ib protein complex. Class Ib here refers to non-classical class I molecules, such as those of the CD1 or HLA-E gene families.
2010-11-18 GO:0002505 antigen processing and presentation of polysaccharide antigen via MHC class II Added DEFINITION The process in which an antigen-presenting cell expresses a polysaccharide antigen on its cell surface in association with an MHC class II protein complex.
2010-11-18 GO:0002549 negative regulation of plasma kallikrein-kinin cascade Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate, or extent of the plasma kallikrein-kinin cascade.
2010-11-18 GO:0002565 somatic diversification of immune receptors via gene conversion Added DEFINITION The process in which immune receptor genes are diversified through gene conversion.
2010-11-18 GO:0003039 detection of reduced oxygen by carotid body chemoreceptor signaling Added DEFINITION The process in which information about the levels of oxygen are received and are converted to a molecular signal by chemoreceptors in a carotid body.
2010-11-18 GO:0003052 circadian regulation of systemic arterial blood pressure Added DEFINITION Any process in which an organism modulates its blood pressure at different values with a regularity of approximately 24 hours.
2010-11-18 GO:0003110 positive regulation of the force of heart contraction by neuronal norepinephrine Deleted DEFINITION The process by which the release of norepinephrine from nerve endings modulates the force of heart muscle contraction.
2010-11-18 GO:0002484 antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway Deleted DEFINITION The process by which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC class I protein complex following intracellular transport via an ER pathway. The peptide is typically a fragment of a larger endogenous protein which has been degraded within the cell and becomes associated with the MHC class I molecule in the ER. Class I here refers to classical class I molecules.
2010-11-18 GO:0002202 somatic diversification of variable lymphocyte receptors of jawless fish Deleted DEFINITION The somatic process by means of which sequence diversity of the variable lymphocyte receptors (VLR) of jawless fish is generated.
2010-11-18 GO:0002567 somatic diversification of FREP-based immune receptors Deleted DEFINITION The process by means of which sequence diversity of the FREP-based immune receptors of snails is generated.
2010-11-18 GO:0018009 N-terminal peptidyl-L-cysteine N-palmitoylation Deleted DEFINITION The palmitoylation of the N-terminal cysteine of proteins to form the derivative N-palmitoyl-L-cysteine.
2010-11-18 GO:0003087 positive regulation of the force of heart contraction by neuronal epinephrine Deleted DEFINITION The process by which the release of epinephrine from nerve endings modulates the force of heart muscle contraction.
2010-11-18 GO:0002481 antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent Deleted DEFINITION The process by which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class Ib protein complex following intracellular transport via a TAP (transporter associated with antigen processing) pathway. The peptide is typically a fragment of a larger exogenous protein which has been degraded within the cell and is dependent on TAP transport from the cytosol to ER for association with the MHC class Ib molecule. Class Ib here refers to non-classical class I molecules, such as those of the HLA-E gene family.
2010-11-18 GO:0033007 negative regulation of mast cell activation involved in immune response Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate, or extent of mast cell activation as part of an immune response.
2010-11-18 GO:0003053 circadian regulation of heart rate Deleted DEFINITION Any process by which an organism modulates its heart rate at different values with a regularity of approximately 24 hours.
2010-11-18 GO:0002457 T cell antigen processing and presentation Deleted DEFINITION The process by which a T cell expresses antigen (peptide or lipid) on its cell surface in association with an MHC protein complex.
2010-11-18 GO:0003060 negative regulation of the force of heart contraction by acetylcholine Deleted DEFINITION The process by which acetylcholine released from vagus nerve endings binds to muscarinic receptors and decreases the force of heart muscle contraction.
2010-11-18 GO:0002364 NK T cell lineage commitment Deleted DEFINITION The process by which a pro-T cell becomes committed to becoming an NK T cell.
2010-11-18 GO:0002128 tRNA nucleoside ribose methylation Deleted DEFINITION The process by which the sugar of a nucleoside in tRNA is modified at the 2'O position.
2010-11-18 GO:2000183 negative regulation of progesterone biosynthetic process Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of progesterone biosynthetic process.
2010-11-18 GO:0003033 detection of hypoxic conditions in blood by aortic body chemoreceptor signaling Deleted DEFINITION The process by which information about a lack of oxygen are received and are converted to a molecular signal by chemoreceptors in the aortic bodies.
2010-11-18 GO:0002478 antigen processing and presentation of exogenous peptide antigen Deleted DEFINITION The process by which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC protein complex. The peptide is typically a fragment of a larger exogenous protein which has been degraded within the cell.
2010-11-18 GO:0043371 negative regulation of CD4-positive, alpha-beta T cell differentiation Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate, or extent of CD4-positive, alpha beta T cell differentiation.
2010-11-18 GO:0033624 negative regulation of integrin activation Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate, or extent of integrin activation.
2010-11-18 GO:0002505 antigen processing and presentation of polysaccharide antigen via MHC class II Deleted DEFINITION The process by which an antigen-presenting cell expresses a polysaccharide antigen on its cell surface in association with an MHC class II protein complex.
2010-11-18 GO:0003055 circadian regulation of heart rate by the suprachiasmatic nucleus Deleted DEFINITION The process by which the suprachiasmatic nucleus modulates heart rate at different values with a regularity of approximately 24 hours.
2010-11-18 GO:0003088 positive regulation of the force of heart contraction by circulating epinephrine Deleted DEFINITION The process by which the secretion of epinephrine into the bloodstream modulates the force of heart muscle contraction.
2010-11-18 GO:0002467 germinal center formation Deleted DEFINITION The process by which germinal centers form. A germinal center is a specialized microenvironment formed when activated B cells enter lymphoid follicles. Germinal centers are the foci for B cell proliferation and somatic hypermutation.
2010-11-18 GO:0003058 hormonal regulation of the force of heart contraction Deleted DEFINITION The process by which the hormones modulates the force of heart muscle contraction. A hormone is one of a group of substances formed in very small amounts in one specialized organ or group of cells and carried (sometimes in the bloodstream) to another organ or group of cells, in the same organism, upon which they have a specific regulatory action.
2010-11-18 GO:0001929 negative regulation of exocyst assembly Deleted DEFINITION Any process that stops, prevents or reduces the rate or extent of exocyst assembly.
2010-11-18 GO:0003069 vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure Deleted DEFINITION The process by which acetylcholine signaling causes vasodilation, resulting in a change in blood pressure.
2010-11-18 GO:2000218 negative regulation of invasive growth in response to glucose limitation Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of invasive growth in response to glucose limitation.
2010-11-18 GO:0010360 negative regulation of anion channel activity Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate, or extent of the anion channel activity.
2010-11-18 GO:0007059 chromosome segregation Deleted DEFINITION The process by which genetic material, in the form of chromosomes, is organized into specific structures and then physically separated and apportioned to two or more sets. Chromosome segregation begins with the alignment of chromosomes at the metaphase plate, includes chromosome separation, and ends when chromosomes have completed movement to the spindle poles.
2010-11-18 GO:0002473 non-professional antigen presenting cell antigen processing and presentation Deleted DEFINITION The process by which a non-professional antigen presenting cell expresses antigen (peptide or lipid) on its cell surface in association with an MHC protein complex. Non-professional antigen presenting cells include all cell types but dendritic cells, B cells, T cells, monocytes, macrophages, and neutrophils.
2010-11-18 GO:0001933 negative regulation of protein phosphorylation Deleted DEFINITION Any process that stops, prevents or decreases the rate of addition of phosphate groups to amino acids within a protein.
2010-11-18 GO:0034107 negative regulation of erythrocyte clearance Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate, or extent of erythrocyte clearance.
2010-11-18 GO:2000195 negative regulation of female gonad development Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of female gonad development.
2010-11-18 GO:2000218 negative regulation of invasive growth in response to glucose limitation Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of invasive growth in response to glucose limitation.
2010-11-18 GO:2000230 negative regulation of pancreatic stellate cell proliferation Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of pancreatic stellate cell proliferation.
2010-11-18 GO:0001933 negative regulation of protein phosphorylation Added DEFINITION Any process that stops, prevents or reduces the rate of addition of phosphate groups to amino acids within a protein.
2010-11-18 GO:0002346 B cell positive selection Added DEFINITION Any process in which B cells are selected to survive based on signaling through the B cell antigen receptor.
2010-11-18 GO:0002348 central B cell positive selection Added DEFINITION Any process leading to positive selection of B cells in the bone marrow. Positive selection is the process in which B or T cells are selected to survive based on signaling through their antigen receptors.
2010-11-18 GO:0002469 myeloid dendritic cell antigen processing and presentation Added DEFINITION The process in which a myeloid dendritic cell expresses antigen (peptide or lipid) on its cell surface in association with an MHC protein complex.
2010-11-18 GO:0002562 somatic diversification of immune receptors via germline recombination within a single locus Added DEFINITION The process in which immune receptor genes are diversified through recombination of the germline genetic elements within a single genetic locus.
2010-11-18 GO:0003005 follicular fluid formation in ovarian follicle antrum involved in scattered antral spaces stage Added DEFINITION The menstrual cycle process in which one central cavity separating the oocyte/cumulus complex from mural granulosa and theca cells is formed as part of the scattered antral spaces stage of oogenesis.
2010-11-18 GO:0003033 detection of hypoxic conditions in blood by aortic body chemoreceptor signaling Added DEFINITION The process in which information about a lack of oxygen are received and are converted to a molecular signal by chemoreceptors in the aortic bodies.
2010-11-18 GO:0003151 outflow tract morphogenesis Added DEFINITION The process in which the anatomical structures of the outflow tract are generated and organized. Morphogenesis pertains to the creation of form. The outflow tract is the portion of the heart through which blood flows into the arteries.
2010-11-18 GO:0003160 endocardium morphogenesis Added DEFINITION The process in which the anatomical structure of the endocardium is generated and organized. The endocardium is an anatomical structure comprised of an endothelium and an extracellular matrix that forms the innermost layer of tissue of the heart, and lines the heart chambers.
2010-11-18 GO:0016445 somatic diversification of immunoglobulins Added DEFINITION The somatic process that results in the generation of sequence diversity of immunoglobulins.
2010-11-18 GO:0072365 regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter Added DEFINITION Any process that modulates the frequency, rate or extent of a cellular ketone metabolic process by stopping, preventing, or reducing the frequency, rate or extent of transcription from an RNA polymerase II promoter.
2010-11-18 GO:0003001 generation of a signal involved in cell-cell signaling Added DEFINITION The cellular process that creates a physical entity or change in state, i.e. a signal, that originates in one cell and is used to transfer information to another cell. This process begins with the initial formation of the signal and ends with the mature form and placement of the signal.
2010-11-18 GO:0003006 developmental process involved in reproduction Added DEFINITION A developmental process in which a progressive change in the state of some part of an organism specifically contributes to its ability to form offspring.
2010-11-18 GO:0003055 circadian regulation of heart rate by the suprachiasmatic nucleus Added DEFINITION The process in which the suprachiasmatic nucleus modulates heart rate at different values with a regularity of approximately 24 hours.
2010-11-18 GO:0003086 regulation of systemic arterial blood pressure by local renal renin-angiotensin Added DEFINITION The process in which angiotensinogen metabolites in the kidney modulate the force with which blood passes through the renal circulatory system. The process begins when renin cleaves angiotensinogen.
2010-11-18 GO:0003095 pressure natriuresis Added DEFINITION The process in which the volume of blood increases renal pressure and results in an increase in natriuresis and diuresis.
2010-11-18 GO:0003106 negative regulation of glomerular filtration by angiotensin Added DEFINITION The process in which angiotensin directly decreases the rate of glomerular filtration in the kidney. Glomerular filtration is the processs whereby blood is filtered by the glomerulus into the renal tubule.
2010-11-18 GO:0001953 negative regulation of cell-matrix adhesion Deleted DEFINITION Any process that stops, prevents or reduces the rate or extent of cell adhesion to the extracellular matrix.
2010-11-18 GO:0018221 peptidyl-serine palmitoylation Deleted DEFINITION The palmitoylation of peptidyl-serine to form peptidyl-O-palmitoyl-L-threonine.
2010-11-18 GO:2000192 negative regulation of fatty acid transport Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of fatty acid transport.
2010-11-18 GO:0002201 somatic diversification of DSCAM-based immune receptors Deleted DEFINITION The somatic process by means of which sequence diversity of the DSCAM-based immune receptors of insects is generated.
2010-11-18 GO:2000140 negative regulation of octopamine signaling pathway involved in response to food Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of octopamine signaling pathway involved in response to food.
2010-11-18 GO:0010360 negative regulation of anion channel activity Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate, or extent of the anion channel activity.
2010-11-18 GO:0010362 negative regulation of anion channel activity by blue light Added DEFINITION Any process by which blue light stops, prevents, or reduces the frequency, rate, or extent of the anion channel activity.
2010-11-18 GO:0017014 protein nitrosylation Added DEFINITION The covalent addition of a nitric oxide group to an amino acid within a protein.
2010-11-18 GO:0018230 peptidyl-L-cysteine S-palmitoylation Added DEFINITION The covalent attachment of a palmitoyl group to a sulfur (S) atom within a cysteine residue to form peptidyl-S-palmitoyl-L-cysteine.
2010-11-18 GO:0033007 negative regulation of mast cell activation involved in immune response Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate, or extent of mast cell activation as part of an immune response.
2010-11-18 GO:0035605 peptidyl-cysteine S-nitrosylase activity Added DEFINITION Catalysis of the transfer of a nitric oxide (NO) group to a sulphur atom within a cysteine residue of a protein.
2010-11-18 GO:2000149 negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of planar cell polarity pathway involved in ventricular septum morphogenesis.
2010-11-18 GO:2000154 negative regulation of flagellar cell motility Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of flagellar cell motility.
2010-11-18 GO:2000166 negative regulation of planar cell polarity pathway involved in pericardium morphogenesis Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of planar cell polarity pathway involved in pericardium morphogenesis.
2010-11-18 GO:2000171 negative regulation of dendrite development Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of dendrite development.
2010-11-18 GO:2000175 negative regulation of pro-T cell differentiation Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of pro-T cell differentiation.
2010-11-18 GO:2000215 negative regulation of proline metabolic process Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of proline metabolic process.
2010-11-18 GO:0003002 regionalization Deleted DEFINITION The pattern specification process by which an axis or axes is subdivided in space to define an area or volume in which specific patterns of cell differentiation will take place or in which cells interpret a specific environment.
2010-11-18 GO:0003083 negative regulation of renal output by angiotensin Deleted DEFINITION The process by which angiotensin directly decreases the rate of natriuresis and diuresis in the kidney.
2010-11-18 GO:0034115 negative regulation of heterotypic cell-cell adhesion Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate, or extent of heterotypic cell-cell adhesion.
2010-11-18 GO:0003020 detection of reduced oxygen by chemoreceptor signaling Deleted DEFINITION The process by which information about the levels of oxygen are received and are converted to a molecular signal by chemoreceptors in the carotid bodies and the aortic bodies.
2010-11-18 GO:0003086 regulation of systemic arterial blood pressure by local renal renin-angiotensin Deleted DEFINITION The process by which angiotensinogen metabolites in the kidney modulate the force with which blood passes through the renal circulatory system. The process begins when renin cleaves angiotensinogen.
2010-11-18 GO:0003029 detection of hypoxic conditions in blood by carotid body chemoreceptor signaling Deleted DEFINITION The process by which information about a lack of oxygen are received and are converted to a molecular signal by chemoreceptors in the carotid bodies.
2010-11-18 GO:0001945 lymph vessel development Deleted DEFINITION The process whose specific outcome is the progression of the lymphatic vasculature over time, from its formation to the mature structure.
2010-11-18 GO:0034111 negative regulation of homotypic cell-cell adhesion Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate, or extent of homotypic cell-cell adhesion.
2010-11-18 GO:0002483 antigen processing and presentation of endogenous peptide antigen Deleted DEFINITION The process by which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC protein complex. The peptide is typically a fragment of a larger endogenous protein which has been degraded within the cell.
2010-11-18 GO:0003149 membranous septum morphogenesis Deleted DEFINITION The process by which the membranous septum is generated and organized. The membranous septum is the upper part of ventricular septum. Morphogenesis pertains to the creation of form.
2010-11-18 GO:0003063 negative regulation of heart rate by acetylcholine Deleted DEFINITION The process by which acetylcholine released from vagus nerve endings binds to muscarinic receptors on the pacemaker cells and decreases the rate of heart muscle contraction.
2010-11-18 GO:2000230 negative regulation of pancreatic stellate cell proliferation Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of pancreatic stellate cell proliferation.
2010-11-18 GO:0002208 somatic diversification of immunoglobulins involved in immune response Deleted DEFINITION The somatic process by means of which sequence diversity of immunoglobulins is generated after the induction and contributing to an immune response.
2010-11-18 GO:0003037 detection of pH by carotid body chemoreceptor signaling Deleted DEFINITION The process by which information about the levels of hydrogen ions are received and are converted to a molecular signal by chemoreceptors in a carotid body.
2010-11-18 GO:0033633 negative regulation of cell-cell adhesion mediated by integrin Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate, or extent of cell-cell adhesion mediated by integrin.
2010-11-18 GO:0003150 muscular septum morphogenesis Deleted DEFINITION The process by which the muscular septum is generated and organized. The muscular septum is the lower part of the ventricular septum.
2010-11-18 GO:2000160 negative regulation of planar cell polarity pathway involved in heart morphogenesis Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of planar cell polarity pathway involved in heart morphogenesis.
2010-11-18 GO:0002485 antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent Deleted DEFINITION The process by which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC class I protein complex following intracellular transport via a TAP-dependent ER pathway. The peptide is typically a fragment of a larger endogenous protein which has been degraded within the cell and becomes associated with the MHC class I molecule in the ER following TAP-dependent transport from the cytosol. Class I here refers to classical class I molecules.
2010-11-18 GO:0002504 antigen processing and presentation of peptide or polysaccharide antigen via MHC class II Deleted DEFINITION The process by which an antigen-presenting cell expresses antigen (peptide or polysaccharide) on its cell surface in association with an MHC class II protein complex.
2010-11-18 GO:2000164 negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of planar cell polarity pathway involved in outflow tract morphogenesis.
2010-11-18 GO:2000178 negative regulation of neural precursor cell proliferation Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of neural precursor cell proliferation.
2010-11-18 GO:0003005 follicular fluid formation in ovarian follicle antrum involved in scattered antral spaces stage Deleted DEFINITION The menstrual cycle process by which one central cavity separating the oocyte/cumulus complex from mural granulosa and theca cells is formed as part of the scattered antral spaces stage of oogenesis.
2010-11-18 GO:2000173 negative regulation of branching morphogenesis of a nerve Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of branching morphogenesis of a nerve.
2010-11-18 GO:0003034 detection of increased carbon dioxide by aortic body chemoreceptor signaling Deleted DEFINITION The process by which information about the levels of carbon dioxideare received and are converted to a molecular signal by chemoreceptors in an aortic body.
2010-11-18 GO:0003146 heart jogging Deleted DEFINITION The morphogenetic process by which the heart cone is displaced to the left with respect to the vector of the anterior-posterior axis.
2010-11-18 GO:2000143 negative regulation of DNA-templated transcription, initiation Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of transcription initiation.
2010-11-18 GO:0002490 antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-independent Deleted DEFINITION The process by which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC class Ib protein complex following intracellular transport via a pathway not requiring TAP (transporter associated with antigen processing). The peptide is typically a fragment of a larger endogenous protein which has been degraded within the cell. Class Ib here refers to non-classical class I molecules, such as those of the HLA-E gene family.
2010-11-18 GO:2000236 negative regulation of tRNA processing Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of tRNA processing.
2010-11-18 GO:0003040 excitation of vasomotor center by aortic body chemoreceptor signaling Deleted DEFINITION The process by which the molecular signal from an aortic body is relayed to the vasomotor center, causing it to signal an increase arterial pressure.
2010-11-18 GO:0003139 secondary heart field specification Deleted DEFINITION The process by which a specific region of the lateral mesoderm is delineated into the area which will form the majority of the mesodermal component of the right ventricle, arterial and venous poles.
2010-11-18 GO:0003148 outflow tract septum morphogenesis Deleted DEFINITION The process by which the anatomical structures of the outflow tract septum are generated and organized. Morphogenesis pertains to the creation of form. The outflow tract septum is a partition in the outflow tract.
2010-11-18 GO:0003053 circadian regulation of heart rate Added DEFINITION Any process in which an organism modulates its heart rate at different values with a regularity of approximately 24 hours.
2010-11-18 GO:0003054 circadian regulation of systemic arterial blood pressure by the suprachiasmatic nucleus Added DEFINITION The process in which the suprachiasmatic nucleus modulates blood pressure at different values with a regularity of approximately 24 hours.
2010-11-18 GO:0003060 negative regulation of the force of heart contraction by acetylcholine Added DEFINITION The process in which acetylcholine released from vagus nerve endings binds to muscarinic receptors and decreases the force of heart muscle contraction.
2010-11-18 GO:0003061 positive regulation of the force of heart contraction by norepinephrine Added DEFINITION The process in which the secretion of norepinephrine into the bloodstream or released from nerve endings modulates the force of heart musclecontraction.
2010-11-18 GO:0003063 negative regulation of heart rate by acetylcholine Added DEFINITION The process in which acetylcholine released from vagus nerve endings binds to muscarinic receptors on the pacemaker cells and decreases the rate of heart muscle contraction.
2010-11-18 GO:0003110 positive regulation of the force of heart contraction by neuronal norepinephrine Added DEFINITION The process in which the release of norepinephrine from nerve endings modulates the force of heart muscle contraction.
2010-11-18 GO:0003113 positive regulation of heart rate by neuronal norepinephrine Added DEFINITION The process in which the secretion of norepinephrine released from nerve endings increases the rate of heart muscle contraction.
2010-11-18 GO:0003114 positive regulation of heart rate by circulating norepinephrine Added DEFINITION The process in which the secretion of norepinephrine into the bloodstream increases the rate of heart muscle contraction.
2010-11-18 GO:0033004 negative regulation of mast cell activation Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate, or extent of mast cell activation.
2010-11-18 GO:0034107 negative regulation of erythrocyte clearance Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate, or extent of erythrocyte clearance.
2010-11-18 GO:0072359 circulatory system development Added DEFINITION The process whose specific outcome is the progression of the circulatory system over time, from its formation to the mature structure. The circulatory system is the organ system that passes nutrients (such as amino acids and electrolytes), gases, hormones, blood cells, etc. to and from cells in the body to help fight diseases and help stabilize body temperature and pH to maintain homeostasis.
2010-11-18 GO:2000140 negative regulation of octopamine signaling pathway involved in response to food Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of octopamine signaling pathway involved in response to food.
2010-11-18 GO:2000146 negative regulation of cell motility Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of cell motility.
2010-11-18 GO:2000151 negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis.
2010-11-18 GO:2000178 negative regulation of neural precursor cell proliferation Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of neural precursor cell proliferation.
2010-11-18 GO:2000180 negative regulation of androgen biosynthetic process Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of androgen biosynthetic process.
2010-11-18 GO:2000221 negative regulation of pseudohyphal growth Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of pseudohyphal growth.
2010-11-18 GO:2000248 negative regulation of establishment or maintenance of neuroblast polarity Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of establishment or maintenance of neuroblast polarity.
2010-11-18 GO:0001944 vasculature development Added DEFINITION The process whose specific outcome is the progression of the vasculature over time, from its formation to the mature structure. The vasculature is an interconnected tubular multi-tissue structure that contains fluid that is actively transported around the organism.
2010-11-18 GO:0002336 B-1 B cell lineage commitment Added DEFINITION The process in which an immature B cell becomes committed to become a B-1 B cell.
2010-11-18 GO:0002362 CD4-positive, CD25-positive, alpha-beta regulatory T cell lineage commitment Added DEFINITION The process in which a CD4-positive, alpha-beta T cell becomes committed to becoming a CD4-positive, CD25-positive, alpha-beta regulatory T cell.
2010-11-18 GO:0072364 regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter Added RELATION is a GO:0010565 (regulation of cellular ketone metabolic process)
2010-11-18 GO:0072364 regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter Added RELATION is a GO:0006357 (regulation of transcription from RNA polymerase II promoter)
2010-11-18 GO:0072365 regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter Added RELATION is a GO:0000122 (negative regulation of transcription from RNA polymerase II promoter)
2010-11-18 GO:0072365 regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter Added RELATION is a GO:0072364 (regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter)
2010-11-18 GO:0072366 regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter Added RELATION is a GO:0045944 (positive regulation of transcription from RNA polymerase II promoter)
2010-11-18 GO:0072366 regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter Added RELATION is a GO:0072364 (regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter)
2010-11-18 GO:0072358 cardiovascular system development Added RELATION is a GO:0048731 (system development)
2010-11-18 GO:0072367 regulation of lipid transport by regulation of transcription from RNA polymerase II promoter Added RELATION is a GO:0006357 (regulation of transcription from RNA polymerase II promoter)
2010-11-18 GO:0072367 regulation of lipid transport by regulation of transcription from RNA polymerase II promoter Added RELATION is a GO:0032368 (regulation of lipid transport)
2010-11-18 GO:0072368 regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter Added RELATION is a GO:0000122 (negative regulation of transcription from RNA polymerase II promoter)
2010-11-18 GO:0072368 regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter Added RELATION is a GO:0072367 (regulation of lipid transport by regulation of transcription from RNA polymerase II promoter)
2010-11-18 GO:0072369 regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter Added RELATION is a GO:0045944 (positive regulation of transcription from RNA polymerase II promoter)
2010-11-18 GO:0072369 regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter Added RELATION is a GO:0072367 (regulation of lipid transport by regulation of transcription from RNA polymerase II promoter)
2010-11-18 GO:0072370 histone H2A-S121 phosphorylation Added RELATION is a GO:0035404 (histone-serine phosphorylation)
2010-11-18 GO:0072371 histone kinase activity (H2A-S121 specific) Added RELATION is a GO:0035174 (histone serine kinase activity)
2010-11-18 GO:0072371 histone kinase activity (H2A-S121 specific) Added RELATION part of GO:0072370 (histone H2A-S121 phosphorylation)
2010-11-18 GO:0071999 extracellular polysaccharide catabolic process Added RELATION is a GO:0046379 (extracellular polysaccharide metabolic process)
2010-11-18 GO:0072358 cardiovascular system development Added RELATION part of GO:0072359 (circulatory system development)
2010-11-18 GO:0072359 circulatory system development Added RELATION is a GO:0048731 (system development)
2010-11-18 GO:0072360 vascular cord development Added RELATION part of GO:0072358 (cardiovascular system development)
2010-11-18 GO:0072360 vascular cord development Added RELATION is a GO:0048856 (anatomical structure development)
2010-11-18 GO:0072361 regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter Added RELATION is a GO:0006110 (regulation of glycolytic process)
2010-11-18 GO:0072361 regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter Added RELATION is a GO:0006357 (regulation of transcription from RNA polymerase II promoter)
2010-11-18 GO:0072362 regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter Added RELATION is a GO:0000122 (negative regulation of transcription from RNA polymerase II promoter)
2010-11-18 GO:0072362 regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter Added RELATION is a GO:0072361 (regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter)
2010-11-18 GO:0072363 regulation of glycolytic by positive regulation of transcription from RNA polymerase II promoter Added RELATION is a GO:0072361 (regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter)
2010-11-18 GO:0072363 regulation of glycolytic by positive regulation of transcription from RNA polymerase II promoter Added RELATION is a GO:0045944 (positive regulation of transcription from RNA polymerase II promoter)
2010-11-18 GO:0035605 peptidyl-cysteine S-nitrosylase activity Added RELATION is a GO:0016769 (transferase activity, transferring nitrogenous groups)
2010-11-18 GO:0035605 peptidyl-cysteine S-nitrosylase activity Added RELATION part of GO:0018119 (peptidyl-cysteine S-nitrosylation)
2010-11-18 GO:0035606 peptidyl-cysteine S-trans-nitrosylation Added RELATION is a GO:0018119 (peptidyl-cysteine S-nitrosylation)
2010-11-18 GO:0035607 fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development Added RELATION part of GO:0021769 (orbitofrontal cortex development)
2010-11-18 GO:0035607 fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development Added RELATION is a GO:0008543 (fibroblast growth factor receptor signaling pathway)
2010-11-18 GO:0007507 heart development Added RELATION part of GO:0072358 (cardiovascular system development)
2010-11-18 GO:0001944 vasculature development Added RELATION is a GO:0048731 (system development)
2010-11-18 GO:0001944 vasculature development Added RELATION part of GO:0072358 (cardiovascular system development)
2010-11-18 GO:0001944 vasculature development Deleted RELATION is a GO:0048856 (anatomical structure development)
2010-11-18 GO:0000910 cytokinesis Added RELATION part of GO:0051301 (cell division)
2010-11-18 GO:0000910 cytokinesis Added RELATION is a GO:0009987 (cellular process)
2010-11-18 GO:0000910 cytokinesis Deleted RELATION is a GO:0051301 (cell division)
2010-11-18 GO:0018221 peptidyl-serine palmitoylation Added SYNONYM peptidyl-serine O-palmitoylation
2010-11-18 GO:0035605 peptidyl-cysteine S-nitrosylase activity Added SYNONYM protein nitrosylase activity
2010-11-18 GO:0000769 syncytium formation by mitosis without cytokinesis Added SYNONYM syncytium formation by mitosis without cell division
2010-11-18 GO:0018220 peptidyl-threonine palmitoylation Added SYNONYM peptidyl-threonine O-palmitoylation
2010-11-18 GO:0051456 attachment of spindle microtubules to kinetochore involved in meiotic sister chromatid segregation Added SYNONYM meiotic bipolar attachment
2010-11-18 GO:0001944 vasculature development Added SYNONYM vascular system development
2010-11-18 GO:0035606 peptidyl-cysteine S-trans-nitrosylation Added SYNONYM cysteine-to-cysteine transnitrosylation
2010-11-18 GO:0072370 histone H2A-S121 phosphorylation Added SYNONYM histone H2AS121 phosphorylation
2010-11-18 GO:0035607 fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development Added SYNONYM FGFR signaling pathway involved in orbitofrontal cortex development
2010-11-18 GO:0072371 histone kinase activity (H2A-S121 specific) Added SYNONYM histone-serine kinase activity (H2A-S121 specific)
2010-11-18 GO:0072371 histone kinase activity (H2A-S121 specific) Added SYNONYM histone serine kinase activity (H2A-S121 specific)
2010-11-18 GO:0035606 peptidyl-cysteine S-trans-nitrosylation Added SYNONYM cysteine to cysteine nitrosylation
2010-11-18 GO:0072364 regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter Added SYNONYM regulation of cellular ketone metabolism by regulation of transcription from an RNA polymerase II promoter
2010-11-18 GO:0072366 regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter Added SYNONYM regulation of cellular ketone metabolism by positive regulation of transcription from an RNA polymerase II promoter
2010-11-18 GO:0018119 peptidyl-cysteine S-nitrosylation Added SYNONYM protein S-nitrosylation
2010-11-18 GO:0018119 peptidyl-cysteine S-nitrosylation Added SYNONYM S-nitrosylation
2010-11-18 GO:0051315 attachment of spindle microtubules to kinetochore involved in mitotic sister chromatid segregation Added SYNONYM mitotic bipolar attachment
2010-11-18 GO:0035606 peptidyl-cysteine S-trans-nitrosylation Added SYNONYM S-transnitrosylation
2010-11-18 GO:0035605 peptidyl-cysteine S-nitrosylase activity Added SYNONYM S-nitrosylase activity
2010-11-18 GO:0035607 fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development Added SYNONYM fibroblast growth factor receptor signalling pathway involved in orbitofrontal cortex development
2010-11-18 GO:0072365 regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter Added SYNONYM regulation of cellular ketone metabolism by negative regulation of transcription from an RNA polymerase II promoter
2010-11-18 GO:0035606 peptidyl-cysteine S-trans-nitrosylation Added SYNONYM protein-to-protein transnitrosylation
2010-11-18 GO:0035607 fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development Added SYNONYM FGF receptor signaling pathway involved in orbitofrontal cortex development
2010-11-18 GO:0072370 histone H2A-S121 phosphorylation Added SYNONYM histone H2A phosphorylation at S121
2010-11-18 GO:0003139 secondary heart field specification Added DEFINITION The process that results in the deliniation of a specific region of the lateral mesoderm into the area which will form the majority of the mesodermal component of the right ventricle, arterial and venous poles.

Terms

Timestamp GO ID GO Term Name Action Category Detail
2010-11-18 GO:0000769 syncytium formation by mitosis without cytokinesis Updated TERM syncytium formation by mitosis without cytokinesis
2010-11-18 GO:0072358 cardiovascular system development Added TERM cardiovascular system development
2010-11-18 GO:0072359 circulatory system development Added TERM circulatory system development
2010-11-18 GO:0072360 vascular cord development Added TERM vascular cord development
2010-11-18 GO:0072361 regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter Added TERM regulation of glycolysis by regulation of transcription from an RNA polymerase II promoter
2010-11-18 GO:0072362 regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter Added TERM regulation of glycolysis by negative regulation of transcription from an RNA polymerase II promoter
2010-11-18 GO:0072365 regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter Added TERM regulation of cellular ketone metabolic process by negative regulation of transcription from an RNA polymerase II promoter
2010-11-18 GO:0072366 regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter Added TERM regulation of cellular ketone metabolic process by positive regulation of transcription from an RNA polymerase II promoter
2010-11-18 GO:0072367 regulation of lipid transport by regulation of transcription from RNA polymerase II promoter Added TERM regulation of lipid transport by regulation of transcription from an RNA polymerase II promoter
2010-11-18 GO:0072368 regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter Added TERM regulation of lipid transport by negative regulation of transcription from an RNA polymerase II promoter
2010-11-18 GO:0072369 regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter Added TERM regulation of lipid transport by positive regulation of transcription from an RNA polymerase II promoter
2010-11-18 GO:0072363 regulation of glycolytic by positive regulation of transcription from RNA polymerase II promoter Added TERM regulation of glycolysis by positive regulation of transcription from an RNA polymerase II promoter
2010-11-18 GO:0072364 regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter Added TERM regulation of cellular ketone metabolic process by regulation of transcription from an RNA polymerase II promoter
2010-11-18 GO:0035605 peptidyl-cysteine S-nitrosylase activity Added TERM peptidyl-cysteine S-nitrosylase activity
2010-11-18 GO:0035606 peptidyl-cysteine S-trans-nitrosylation Added TERM peptidyl-cysteine S-trans-nitrosylation
2010-11-18 GO:0035607 fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development Added TERM fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development
2010-11-18 GO:0072370 histone H2A-S121 phosphorylation Added TERM histone H2A-S121 phosphorylation
2010-11-18 GO:0072371 histone kinase activity (H2A-S121 specific) Added TERM histone kinase activity (H2A-S121 specific)

Definition/synonyms

Timestamp GO ID GO Term Name Action Category Detail
2010-11-18 GO:0002450 B cell antigen processing and presentation Added DEFINITION The process in which a B cell expresses antigen (peptide or lipid) on its cell surface in association with an MHC protein complex.
2010-11-18 GO:0002457 T cell antigen processing and presentation Added DEFINITION The process in which a T cell expresses antigen (peptide or lipid) on its cell surface in association with an MHC protein complex.
2010-11-18 GO:0002489 antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent Added DEFINITION The process in which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC class Ib protein complex following intracellular transport via a TAP (transporter associated with antigen processing) pathway. The peptide is typically a fragment of a larger endogenous protein which has been degraded within the cell and is dependent on TAP transport from the cytosol to ER for association with the MHC class Ib molecule. Class Ib here refers to non-classical class I molecules, such as those of the HLA-E gene family.
2010-11-18 GO:0002491 antigen processing and presentation of endogenous peptide antigen via MHC class II Added DEFINITION The process in which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC class II protein complex. The peptide antigen is typically, but not always, processed from a whole protein.
2010-11-18 GO:0002680 pro-T cell lineage commitment Added DEFINITION The process in which a lymphoid progenitor cell becomes committed to becoming a pro-T cell.
2010-11-18 GO:0003003 follicular fluid formation in ovarian follicle antrum involved in fused antrum stage Added DEFINITION The ovulation cycle process in which one central cavity separating the oocyte/cumulus complex from mural granulosa and theca cells is formed as part of the fused antrum stage of oogenesis.
2010-11-18 GO:0003019 central nervous system control of baroreceptor feedback Added DEFINITION The neurological process in which nerve impulses arising in the aorta or the carotid sinuses travel to the medulla and reach the nucleus of tractus solaris.
2010-11-18 GO:0003021 detection of increased carbon dioxide by chemoreceptor signaling Added DEFINITION The process in which information about the levels of carbon dioxideare received and are converted to a molecular signal by chemoreceptors in the carotid bodies and the aortic bodies.
2010-11-18 GO:0003035 detection of increased carbon dioxide by carotid body chemoreceptor signaling Added DEFINITION The process in which information about the levels of carbon dioxide are received and are converted to a molecular signal by chemoreceptors in a carotid body.
2010-11-18 GO:2000242 negative regulation of reproductive process Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of reproductive process.
2010-11-18 GO:0003107 positive regulation of natriuresis by angiotensin Added DEFINITION The process in which angiotensin increases the rate of natriuresis indirectly via diuresis. Natriuresis is the process of renal sodium excretion.
2010-11-18 GO:0003109 positive regulation of the force of heart contraction by circulating norepinephrine Added DEFINITION The process in which the secretion of norepinephrine into the bloodstream modulates the force of heart muscle contraction.
2010-11-18 GO:0003111 positive regulation of heart rate by circulating epinephrine Added DEFINITION The process in which the secretion of epinephrine into the bloodstream increases the rate of heart muscle contraction.
2010-11-18 GO:0003159 morphogenesis of an endothelium Added DEFINITION The process in which the anatomical structure of an endothelium is generated and organized. An endothelium is an epithelium that lines an anatomical structure.
2010-11-18 GO:0018119 peptidyl-cysteine S-nitrosylation Added DEFINITION The covalent addition of a nitric oxide (NO) group to the sulphur (S) atom of a cysteine residue in a protein, to form peptidyl-S-nitrosyl-L-cysteine.
2010-11-18 GO:0018220 peptidyl-threonine palmitoylation Added DEFINITION The covalent attachment of a palmitoyl group to an oxygen (O) atom in a threonine residue to form peptidyl-O-palmitoyl-L-threonine.
2010-11-18 GO:0072362 regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter Added DEFINITION Any process that modulates the frequency, rate or extent of glycolysis by stopping, preventing, or reducing the frequency, rate or extent of transcription from an RNA polymerase II promoter.
2010-11-18 GO:2000168 negative regulation of planar cell polarity pathway involved in neural tube closure Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of planar cell polarity pathway involved in neural tube closure.
2010-11-18 GO:2000181 negative regulation of blood vessel morphogenesis Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of blood vessel morphogenesis.
2010-11-18 GO:2000186 negative regulation of phosphate transmembrane transport Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of phosphate transmembrane transport.
2010-11-18 GO:2000190 negative regulation of regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor.
2010-11-18 GO:2000212 negative regulation of glutamate metabolic process Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of glutamate metabolic process.
2010-11-18 GO:2000233 negative regulation of rRNA processing Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of rRNA processing.
2010-11-18 GO:2000236 negative regulation of tRNA processing Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of tRNA processing.
2010-11-18 GO:0001929 negative regulation of exocyst assembly Added DEFINITION Any process that stops, prevents, or reduces the rate or extent of exocyst assembly.
2010-11-18 GO:0002128 tRNA nucleoside ribose methylation Added DEFINITION The process that results in the modification of the sugar of a nucleoside in tRNA at the 2'O position.
2010-11-18 GO:0002175 protein localization to paranode region of axon Added DEFINITION A cellular protein localization process in which a protein is transported to, or maintained at, the paranode region of an axon.
2010-11-18 GO:0002201 somatic diversification of DSCAM-based immune receptors Added DEFINITION The somatic process that results in the generation of sequence diversity of the DSCAM-based immune receptors of insects.
2010-11-18 GO:0002504 antigen processing and presentation of peptide or polysaccharide antigen via MHC class II Added DEFINITION The process in which an antigen-presenting cell expresses antigen (peptide or polysaccharide) on its cell surface in association with an MHC class II protein complex.
2010-11-18 GO:0002344 B cell affinity maturation Added DEFINITION The process in which B cells produce antibodies with increased antigen affinity. This is accomplished by somatic hypermutation and selection for B cells which produce higher affinity antibodies to antigen.
2010-11-18 GO:0002363 alpha-beta T cell lineage commitment Added DEFINITION The process in which a pro-T cell becomes committed to becoming an alpha-beta T cell.
2010-11-18 GO:0002364 NK T cell lineage commitment Added DEFINITION The process in which a pro-T cell becomes committed to becoming an NK T cell.
2010-11-18 GO:0002468 dendritic cell antigen processing and presentation Added DEFINITION The process in which a dendritic cell expresses antigen (peptide or lipid) on its cell surface in association with an MHC protein complex.
2010-11-18 GO:0002471 monocyte antigen processing and presentation Added DEFINITION The process in which a monocyte expresses antigen (peptide or lipid) on its cell surface in association with an MHC protein complex.
2010-11-18 GO:0002478 antigen processing and presentation of exogenous peptide antigen Added DEFINITION The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC protein complex. The peptide is typically a fragment of a larger exogenous protein which has been degraded within the cell.
2010-11-18 GO:0002480 antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent Added DEFINITION The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class I protein complex following intracellular transport via a pathway not requiring TAP (transporter associated with antigen processing). The peptide is typically a fragment of a larger exogenous protein which has been degraded within the cell. Class I here refers to classical class I molecules.
2010-11-18 GO:0002486 antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent Added DEFINITION The process in which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC class I protein complex following intracellular transport via a TAP-independent ER pathway. The peptide is typically a fragment of a larger endogenous protein which has been degraded within the cell and becomes associated with the MHC class I molecule in the ER following transport from the cytosol via a TAP-independent pathway. Class I here refers to classical class I molecules.
2010-11-18 GO:0002487 antigen processing and presentation of endogenous peptide antigen via MHC class I via endolysosomal pathway Added DEFINITION The process in which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC class I protein complex. The peptide is typically a fragment of a larger endogenous protein which has been degraded within the cell and becomes associated with the MHC class I molecule in an endolysosome. Class I here refers to classical class I molecules.
2010-11-18 GO:0002490 antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-independent Added DEFINITION The process in which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC class Ib protein complex following intracellular transport via a pathway not requiring TAP (transporter associated with antigen processing). The peptide is typically a fragment of a larger endogenous protein which has been degraded within the cell. Class Ib here refers to non-classical class I molecules, such as those of the HLA-E gene family.
2010-11-18 GO:0002681 somatic recombination of T cell receptor gene segments Added DEFINITION The process in which T cell receptor genes are formed through recombination of the germline genetic elements, also known as T cell receptor gene segments.
2010-11-18 GO:0003029 detection of hypoxic conditions in blood by carotid body chemoreceptor signaling Added DEFINITION The process in which information about a lack of oxygen are received and are converted to a molecular signal by chemoreceptors in the carotid bodies.
2010-11-18 GO:0003069 vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure Added DEFINITION The process in which acetylcholine signaling causes vasodilation, resulting in a change in blood pressure.
2010-11-18 GO:0003098 tubuloglomerular feedback Added DEFINITION The process in which blood volume is regulated due to a change in the rate of glomerular filtration. This is accomplished by a feedback mechanism that senses changes in the juxtaglomerular apparatus.
2010-11-18 GO:0003101 regulation of systemic arterial blood pressure by circulatory epinephrine-norepinephrine Added DEFINITION The process in which epinephrine-norepinephrine modulate the force with which blood passes through the circulatory system.
2010-11-18 GO:0002563 somatic diversification of immune receptors via alternate splicing Added DEFINITION The process in which immune receptor genes are diversified through alternate splicing.
2010-11-18 GO:0003083 negative regulation of renal output by angiotensin Added DEFINITION The process in which angiotensin directly decreases the rate of natriuresis and diuresis in the kidney.
2010-11-18 GO:0003100 regulation of systemic arterial blood pressure by endothelin Added DEFINITION The process in which endothelin modulates the force with which blood passes through the circulatory system. Endothelin is a hormone that is released by the endothelium, and it is a vasoconstrictor.
2010-11-18 GO:0003128 heart field specification Added DEFINITION The process that results in the delineation of a specific region of the lateral mesoderm into the area in which the heart will develop.
2010-11-18 GO:0003143 embryonic heart tube morphogenesis Added DEFINITION The process in which the anatomical structures of the embryonic heart tube are generated and organized. Morphogenesis pertains to the creation of form. The embryonic heart tube is an epithelial tube that will give rise to the mature heart.
2010-11-18 GO:0003148 outflow tract septum morphogenesis Added DEFINITION The process in which the anatomical structures of the outflow tract septum are generated and organized. Morphogenesis pertains to the creation of form. The outflow tract septum is a partition in the outflow tract.
2010-11-18 GO:0007059 chromosome segregation Added DEFINITION The process by which genetic material, in the form of chromosomes, is organized into specific structures and then physically separated and apportioned to two or more sets. In eukaryotes, chromosome segregation begins with the alignment of chromosomes at the metaphase plate, includes chromosome separation, and ends when chromosomes have completed movement to the spindle poles.
2010-11-18 GO:0021764 amygdala development Added DEFINITION The progression of the amygdala over time from its initial formation until its mature state. The amygdala is an almond-shaped set of neurons in the medial temporal lobe of the brain that play a key role in processing emotions such as fear and pleasure.
2010-11-18 GO:0034119 negative regulation of erythrocyte aggregation Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate, or extent of erythrocyte aggregation.
2010-11-18 GO:0035607 fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development Added DEFINITION The series of molecular signals generated as a consequence of a fibroblast growth factor-type receptor binding to one of its physiological ligands, which contributes to the progression of the orbitofrontal cortex over time from its initial formation until its mature state.
2010-11-18 GO:0046918 N-terminal peptidyl-glycine N-palmitoylation Added DEFINITION The covalent attachment of a palmitoyl group to a nitrogen (N) atom in an N-terminal glycine residue to form N-palmitoyl-glycine.
2010-11-18 GO:2000143 negative regulation of DNA-templated transcription, initiation Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of transcription initiation.
2010-11-18 GO:2000192 negative regulation of fatty acid transport Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of fatty acid transport.
2010-11-18 GO:2000201 negative regulation of ribosomal subunit export from nucleus Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of ribosomal subunit export from nucleus.
2010-11-18 GO:2000207 negative regulation of ribosomal small subunit export from nucleus Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of ribosomal small subunit export from nucleus.
2010-11-18 GO:2000225 negative regulation of testosterone biosynthetic process Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of testosterone biosynthetic process.
2010-11-18 GO:2000245 negative regulation of FtsZ-dependent cytokinesis Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of cytokinesis by binary fission.
2010-11-18 GO:0001953 negative regulation of cell-matrix adhesion Added DEFINITION Any process that stops, prevents, or reduces the rate or extent of cell adhesion to the extracellular matrix.
2010-11-18 GO:0002202 somatic diversification of variable lymphocyte receptors of jawless fish Added DEFINITION The somatic process that results in the generation of sequence diversity of the variable lymphocyte receptors (VLR) of jawless fish.
2010-11-18 GO:0002206 gene conversion of immunoglobulin genes Added DEFINITION The somatic process in which immunoglobulin genes are diversified through the mechanism of gene conversion.
2010-11-18 GO:0002360 T cell lineage commitment Added DEFINITION The process in which a lymphoid progenitor cell becomes committed to becoming any type of T cell.
2010-11-18 GO:0002470 plasmacytoid dendritic cell antigen processing and presentation Added DEFINITION The process in which a plasmacytoid dendritic cell expresses antigen (peptide or lipid) on its cell surface in association with an MHC protein complex.
2010-11-18 GO:0002484 antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway Added DEFINITION The process in which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC class I protein complex following intracellular transport via an ER pathway. The peptide is typically a fragment of a larger endogenous protein which has been degraded within the cell and becomes associated with the MHC class I molecule in the ER. Class I here refers to classical class I molecules.
2010-11-18 GO:0002488 antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway Added DEFINITION The process in which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC class Ib protein complex following intracellular transport via an ER pathway. The peptide is typically a fragment of a larger endogenous protein which has been degraded within the cell and becomes associated with the MHC class Ib molecule in the ER. Class Ib here refers to non-classical class I molecules, such as those of the HLA-E gene family.
2010-11-18 GO:0002495 antigen processing and presentation of peptide antigen via MHC class II Added DEFINITION The process in which an antigen-presenting cell expresses a peptide antigen on its cell surface in association with an MHC class II protein complex. The peptide antigen is typically, but not always, processed from a whole protein.
2010-11-18 GO:0003002 regionalization Added DEFINITION The pattern specification process that results in the subdivision of an axis or axes in space to define an area or volume in which specific patterns of cell differentiation will take place or in which cells interpret a specific environment.
2010-11-18 GO:0003020 detection of reduced oxygen by chemoreceptor signaling Added DEFINITION The process in which information about the levels of oxygen are received and are converted to a molecular signal by chemoreceptors in the carotid bodies and the aortic bodies.
2010-11-18 GO:0003038 detection of reduced oxygen by aortic body chemoreceptor signaling Added DEFINITION The process in which information about the levels of oxygen are received and are converted to a molecular signal by chemoreceptors in an aortic body.
2010-11-18 GO:0003040 excitation of vasomotor center by aortic body chemoreceptor signaling Added DEFINITION The process in which the molecular signal from an aortic body is relayed to the vasomotor center, causing it to signal an increase arterial pressure.
2010-11-18 GO:0003058 hormonal regulation of the force of heart contraction Added DEFINITION The process in which the hormones modulates the force of heart muscle contraction. A hormone is one of a group of substances formed in very small amounts in one specialized organ or group of cells and carried (sometimes in the bloodstream) to another organ or group of cells, in the same organism, upon which they have a specific regulatory action.
2010-11-18 GO:0003064 regulation of heart rate by hormone Added DEFINITION The process in which the hormones modulates the rate of heart muscle contraction. A hormone is one of a group of substances formed in very small amounts in one specialized organ or group of cells and carried (sometimes in the bloodstream) to another organ or group of cells, in the same organism, upon which they have a specific regulatory action.
2010-11-18 GO:0003146 heart jogging Added DEFINITION The morphogenetic process in which the heart cone is displaced to the left with respect to the vector of the anterior-posterior axis.
2010-11-18 GO:0003149 membranous septum morphogenesis Added DEFINITION The process in which the membranous septum is generated and organized. The membranous septum is the upper part of ventricular septum. Morphogenesis pertains to the creation of form.
2010-11-18 GO:0002567 somatic diversification of FREP-based immune receptors Added DEFINITION The process that results in the generation of sequence diversity of the FREP-based immune receptors of snails.
2010-11-18 GO:0003022 detection of pH by chemoreceptor signaling Added DEFINITION The process in which information about the levels of hydrogen ions are received and are converted to a molecular signal by chemoreceptors in the carotid bodies and the aortic bodies.
2010-11-18 GO:0003041 excitation of vasomotor center by carotid body chemoreceptor signaling Added DEFINITION The process in which the molecular signal from a carotid body is relayed to the vasomotor center, causing it to signal an increase arterial pressure.
2010-11-18 GO:0003059 positive regulation of the force of heart contraction by epinephrine Added DEFINITION The process in which the secretion of epinephrine into the bloodstream or released from nerve endings modulates the force of heart muscle contraction.
2010-11-18 GO:0003150 muscular septum morphogenesis Added DEFINITION The process in which the muscular septum is generated and organized. The muscular septum is the lower part of the ventricular septum.
2010-11-18 GO:0003152 morphogenesis of an epithelial fold involved in embryonic heart tube formation Added DEFINITION The morphogenetic process in which an epithelial sheet bends along a linear axis, contributing to embryonic heart tube formation.
2010-11-18 GO:0018221 peptidyl-serine palmitoylation Added DEFINITION The covalent attachment of a palmitoyl group to an oxygen (O) atom in a serine residue to form peptidyl-O-palmitoyl-L-serine.
2010-11-18 GO:0033629 negative regulation of cell adhesion mediated by integrin Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate, or extent of cell adhesion mediated by integrin.
2010-11-18 GO:0034104 negative regulation of tissue remodeling Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate, or extent of tissue remodeling.
2010-11-18 GO:0034111 negative regulation of homotypic cell-cell adhesion Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate, or extent of homotypic cell-cell adhesion.
2010-11-18 GO:2000250 negative regulation of actin cytoskeleton reorganization Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of actin cytoskeleton reorganization.
2010-11-18 GO:0002207 gene conversion of immunoglobulin genes involved in immune response Added DEFINITION The somatic process in which immunoglobulin genes are diversified through the mechanism of gene conversion following the induction of and contributing to an immune response.
2010-11-18 GO:0002365 gamma-delta T cell lineage commitment Added DEFINITION The process in which a pro-T cell becomes committed to becoming a gamma-delta T cell.
2010-11-18 GO:2000162 negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of planar cell polarity pathway involved in cardiac right atrium morphogenesis.
2010-11-18 GO:2000173 negative regulation of branching morphogenesis of a nerve Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of branching morphogenesis of a nerve.
2010-11-18 GO:0002428 antigen processing and presentation of peptide antigen via MHC class Ib Added DEFINITION The process in which an antigen-presenting cell expresses peptide antigen in association with an MHC class Ib protein complex on its cell surface. The peptide antigen may originate from an endogenous or exogenous protein. Class Ib here refers to non-classical class I molecules, such as those of the HLA-E family.
2010-11-18 GO:0002481 antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent Added DEFINITION The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class Ib protein complex following intracellular transport via a TAP (transporter associated with antigen processing) pathway. The peptide is typically a fragment of a larger exogenous protein which has been degraded within the cell and is dependent on TAP transport from the cytosol to ER for association with the MHC class Ib molecule. Class Ib here refers to non-classical class I molecules, such as those of the HLA-E gene family.
2010-11-18 GO:0003065 positive regulation of heart rate by epinephrine Added DEFINITION The process in which the secretion of epinephrine into the bloodstream or released from nerve endings increases the rate of heart muscle contraction.
2010-11-18 GO:0003066 positive regulation of heart rate by norepinephrine Added DEFINITION The process in which the secretion of norepinephrine into the bloodstream or released from nerve endings increases the rate of heart muscle contraction.
2010-11-18 GO:0003067 circadian regulation of systemic arterial blood pressure by hormone Added DEFINITION The process in which hormones modulate the force with which blood passes through the circulatory system contributing to different values of blood pressure oscillating with a regularity of approximately 24 hours. A hormone is one of a group of substances formed in very small amounts in one specialized organ or group of cells and carried (sometimes in the bloodstream) to another organ or group of cells, in the same organism, upon which they have a specific regulatory action.
2010-11-18 GO:0003087 positive regulation of the force of heart contraction by neuronal epinephrine Added DEFINITION The process in which the release of epinephrine from nerve endings modulates the force of heart muscle contraction.
2010-11-18 GO:0003088 positive regulation of the force of heart contraction by circulating epinephrine Added DEFINITION The process in which the secretion of epinephrine into the bloodstream modulates the force of heart muscle contraction.
2010-11-18 GO:0003142 cardiogenic plate morphogenesis Added DEFINITION The process in which the anatomical structures of the cardiogenic plate are generated and organized. The cardiogenic plate is the first recognizable structure derived from the heart field.
2010-11-18 GO:0033624 negative regulation of integrin activation Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate, or extent of integrin activation.
2010-11-18 GO:0072369 regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter Added DEFINITION Any process that modulates the frequency, rate or extent of lipid transport by activating or increasing the frequency, rate or extent of transcription from an RNA polymerase II promoter.
2010-11-18 GO:0072371 histone kinase activity (H2A-S121 specific) Added DEFINITION Catalysis of the transfer of a phosphate group to the serine-121 residue of the N-terminal tail of histone H2A.
2010-11-18 GO:2000157 negative regulation of ubiquitin-specific protease activity Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of ubiquitin-specific protease activity.
2010-11-18 GO:2000183 negative regulation of progesterone biosynthetic process Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of progesterone biosynthetic process.
2010-11-18 GO:2000204 negative regulation of ribosomal large subunit export from nucleus Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of ribosomal large subunit export from nucleus.
2010-11-18 GO:2000227 negative regulation of pancreatic A cell differentiation Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of pancreatic A cell differentiation.
2010-11-18 GO:0018220 peptidyl-threonine palmitoylation Deleted DEFINITION The palmitoylation of peptidyl-threonine to form peptidyl-O-palmitoyl-L-threonine.
2010-11-18 GO:0034104 negative regulation of tissue remodeling Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate, or extent of tissue remodeling.
2010-11-18 GO:0002428 antigen processing and presentation of peptide antigen via MHC class Ib Deleted DEFINITION The process by which an antigen-presenting cell expresses peptide antigen in association with an MHC class Ib protein complex on its cell surface. The peptide antigen may originate from an endogenous or exogenous protein. Class Ib here refers to non-classical class I molecules, such as those of the HLA-E family.
2010-11-18 GO:2000248 negative regulation of establishment or maintenance of neuroblast polarity Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of establishment or maintenance of neuroblast polarity.
2010-11-18 GO:0002468 dendritic cell antigen processing and presentation Deleted DEFINITION The process by which a dendritic cell expresses antigen (peptide or lipid) on its cell surface in association with an MHC protein complex.
2010-11-18 GO:2000195 negative regulation of female gonad development Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of female gonad development.
2010-11-18 GO:0003128 heart field specification Deleted DEFINITION The process by which a specific region of the lateral mesoderm is delineated into the area in which the heart will develop.
2010-11-18 GO:2000175 negative regulation of pro-T cell differentiation Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of pro-T cell differentiation.
2010-11-18 GO:0002563 somatic diversification of immune receptors via alternate splicing Deleted DEFINITION The process by which immune receptor genes are diversified through alternate splicing.
2010-11-18 GO:0021764 amygdala development Deleted DEFINITION The progression of the amygdala over time from its initial formation until its mature state. The amygdala is an almond shaped set of neurons in the medial temporal lobe of the brain that play a key role in processing emotions such as fear and pleasure.
2010-11-18 GO:0002479 antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent Deleted DEFINITION The process by which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class I protein complex following intracellular transport via a TAP (transporter associated with antigen processing) pathway. The peptide is typically a fragment of a larger exogenous protein which has been degraded within the cell and is dependent on TAP transport from the cytosol to ER for association with the MHC class I molecule. Class I here refers to classical class I molecules.
2010-11-18 GO:0003039 detection of reduced oxygen by carotid body chemoreceptor signaling Deleted DEFINITION The process by which information about the levels of oxygen are received and are converted to a molecular signal by chemoreceptors in a carotid body.
2010-11-18 GO:0002450 B cell antigen processing and presentation Deleted DEFINITION The process by which a B cell expresses antigen (peptide or lipid) on its cell surface in association with an MHC protein complex.
2010-11-18 GO:0003054 circadian regulation of systemic arterial blood pressure by the suprachiasmatic nucleus Deleted DEFINITION The process by which the suprachiasmatic nucleus modulates blood pressure at different values with a regularity of approximately 24 hours.
2010-11-18 GO:0002204 somatic recombination of immunoglobulin genes involved in immune response Deleted DEFINITION The process by which immunoglobulin genes are formed through recombination of the germline genetic elements, also known as immunoglobulin gene segments, within a single locus following the induction of and contributing to an immune response.
2010-11-18 GO:0002175 protein localization to paranode region of axon Deleted DEFINITION Any process by which a protein is transported to, or maintained at, the paranode region of an axon.
2010-11-18 GO:0003052 circadian regulation of systemic arterial blood pressure Deleted DEFINITION Any process by which an organism modulates its blood pressure at different values with a regularity of approximately 24 hours.
2010-11-18 GO:0002475 antigen processing and presentation via MHC class Ib Deleted DEFINITION The process by which an antigen-presenting cell expresses antigen (peptide or lipid) on its cell surface in association with an MHC class Ib protein complex. Class Ib here refers to non-classical class I molecules, such as those of the CD1 or HLA-E gene families.
2010-11-18 GO:0003112 positive regulation of heart rate by neuronal epinephrine Added DEFINITION The process in which the secretion of epinephrine from nerve endings increases the rate of heart muscle contraction.
2010-11-18 GO:0003138 primary heart field specification Added DEFINITION The process that results in the deliniation of a specific region of the lateral mesoderm into the area which will form the primary beating heart tube.
2010-11-18 GO:0018009 N-terminal peptidyl-L-cysteine N-palmitoylation Added DEFINITION The covalent attachment of a palmitoyl group to a nitrogen (N) atom in an N-terminal cysteine residue to form N-palmitoyl-L-cysteine.
2010-11-18 GO:0033633 negative regulation of cell-cell adhesion mediated by integrin Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate, or extent of cell-cell adhesion mediated by integrin.
2010-11-18 GO:0034115 negative regulation of heterotypic cell-cell adhesion Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate, or extent of heterotypic cell-cell adhesion.
2010-11-18 GO:0072363 regulation of glycolytic by positive regulation of transcription from RNA polymerase II promoter Added DEFINITION Any process that modulates the frequency, rate or extent of glycolysis by activating or increasing the frequency, rate or extent of transcription from an RNA polymerase II promoter.
2010-11-18 GO:0072368 regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter Added DEFINITION Any process that modulates the frequency, rate or extent of lipid transport by stopping, preventing, or reducing the frequency, rate or extent of transcription from an RNA polymerase II promoter.
2010-11-18 GO:2000164 negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of planar cell polarity pathway involved in outflow tract morphogenesis.
2010-11-18 GO:2000198 negative regulation of ribonucleoprotein complex localization Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of ribonucleoprotein complex localization.
2010-11-18 GO:2000239 negative regulation of tRNA export from nucleus Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of tRNA export from nucleus.
2010-11-18 GO:0002566 somatic diversification of immune receptors via somatic mutation Added DEFINITION The process in which immune receptor genes are diversified through somatic mutation.
2010-11-18 GO:0003004 follicular fluid formation in ovarian follicle antrum involved in distinct antral spaces stage Added DEFINITION The menstrual cycle process in which one central cavity separating the oocyte/cumulus complex from mural granulosa and theca cells is formed as part of the antral spaces stage of oogenesis.
2010-11-18 GO:0003007 heart morphogenesis Added DEFINITION The developmental process in which the heart is generated and organized. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood.
2010-11-18 GO:0003034 detection of increased carbon dioxide by aortic body chemoreceptor signaling Added DEFINITION The process in which information about the levels of carbon dioxideare received and are converted to a molecular signal by chemoreceptors in an aortic body.
2010-11-18 GO:0003036 detection of pH by aortic body chemoreceptor signaling Added DEFINITION The process in which information about the levels of hydrogen ions are received and are converted to a molecular signal by chemoreceptors in an aortic body.
2010-11-18 GO:0003037 detection of pH by carotid body chemoreceptor signaling Added DEFINITION The process in which information about the levels of hydrogen ions are received and are converted to a molecular signal by chemoreceptors in a carotid body.
2010-11-18 GO:0003081 regulation of systemic arterial blood pressure by renin-angiotensin Added DEFINITION The process in which renin-angiotensin modulates the force with which blood passes through the circulatory system.
2010-11-18 GO:0003082 positive regulation of renal output by angiotensin Added DEFINITION Any process in which angiotensin directly increases the rate of natriuresis and diuresis in the kidney.
2010-11-18 GO:0001944 vasculature development Deleted DEFINITION The process whose specific outcome is the progression of the vasculature over time, from its formation to the mature structure.
2010-11-18 GO:0003098 tubuloglomerular feedback Deleted DEFINITION The process by which blood volume is regulated due to a change in the rate of glomerular filtration. This is accomplished by a feedback mechanism that senses changes in the juxtaglomerular apparatus.
2010-11-18 GO:2000198 negative regulation of ribonucleoprotein complex localization Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of ribonucleoprotein complex localization.
2010-11-18 GO:0002362 CD4-positive, CD25-positive, alpha-beta regulatory T cell lineage commitment Deleted DEFINITION The process by which a CD4-positive, alpha-beta T cell becomes committed to becoming a CD4-positive, CD25-positive, alpha-beta regulatory T cell.
2010-11-18 GO:0046918 N-terminal peptidyl-glycine N-palmitoylation Deleted DEFINITION The palmitoylation of the N-terminal glycine of proteins to form the derivative N-palmitoyl-glycine.
2010-11-18 GO:0003138 primary heart field specification Deleted DEFINITION The process by which a specific region of the lateral mesoderm is delineated into the area which will form the primary beating heart tube.
2010-11-18 GO:0002204 somatic recombination of immunoglobulin genes involved in immune response Added DEFINITION The process in which immunoglobulin genes are formed through recombination of the germline genetic elements, also known as immunoglobulin gene segments, within a single locus following the induction of and contributing to an immune response.
2010-11-18 GO:0002208 somatic diversification of immunoglobulins involved in immune response Added DEFINITION The somatic process that results in the generation of sequence diversity of immunoglobulins after induction, and contributes to an immune response.
2010-11-18 GO:0002350 peripheral B cell positive selection Added DEFINITION Any process leading to positive selection of B cells in the periphery. Positive selection is the process in which B or T cells are selected to survive based on signaling through their antigen receptors.
2010-11-18 GO:0002476 antigen processing and presentation of endogenous peptide antigen via MHC class Ib Added DEFINITION The process in which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC class Ib protein complex. The peptide is typically a fragment of a larger endogenous protein which has been degraded within the cell. Class Ib here refers to non-classical class I molecules, such as those of the HLA-E gene family.
2010-11-18 GO:0002485 antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent Added DEFINITION The process in which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC class I protein complex following intracellular transport via a TAP-dependent ER pathway. The peptide is typically a fragment of a larger endogenous protein which has been degraded within the cell and becomes associated with the MHC class I molecule in the ER following TAP-dependent transport from the cytosol. Class I here refers to classical class I molecules.
2010-11-18 GO:2000180 negative regulation of androgen biosynthetic process Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of androgen biosynthetic process.
2010-11-18 GO:2000157 negative regulation of ubiquitin-specific protease activity Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of ubiquitin-specific protease activity.
2010-11-18 GO:0003065 positive regulation of heart rate by epinephrine Deleted DEFINITION The process by which the secretion of epinephrine into the bloodstream or released from nerve endings increases the rate of heart muscle contraction.
2010-11-18 GO:0002546 negative regulation of tissue kallikrein-kinin cascade Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate, or extent of the tissue kallikrein-kinin cascade.
2010-11-18 GO:0003111 positive regulation of heart rate by circulating epinephrine Deleted DEFINITION The process by which the secretion of epinephrine into the bloodstream increases the rate of heart muscle contraction.
2010-11-18 GO:0002568 somatic diversification of T cell receptor genes Deleted DEFINITION The somatic process by means of which sequence diversity of T cell receptor genes is generated.
2010-11-18 GO:2000162 negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of planar cell polarity pathway involved in cardiac right atrium morphogenesis.
2010-11-18 GO:0003061 positive regulation of the force of heart contraction by norepinephrine Deleted DEFINITION The process by which the secretion of norepinephrine into the bloodstream or released from nerve endings modulates the force of heart musclecontraction.
2010-11-18 GO:0003159 morphogenesis of an endothelium Deleted DEFINITION The process by which the anatomical structure of an endothelium is generated and organized. An endothelium is an epithelium that lines an anatomical structure.
2010-11-18 GO:2000204 negative regulation of ribosomal large subunit export from nucleus Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of ribosomal large subunit export from nucleus.
2010-11-18 GO:0002488 antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway Deleted DEFINITION The process by which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC class Ib protein complex following intracellular transport via an ER pathway. The peptide is typically a fragment of a larger endogenous protein which has been degraded within the cell and becomes associated with the MHC class Ib molecule in the ER. Class Ib here refers to non-classical class I molecules, such as those of the HLA-E gene family.
2010-11-18 GO:2000201 negative regulation of ribosomal subunit export from nucleus Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of ribosomal subunit export from nucleus.
2010-11-18 GO:0002565 somatic diversification of immune receptors via gene conversion Deleted DEFINITION The process by which immune receptor genes are diversified through gene conversion.
2010-11-18 GO:0003081 regulation of systemic arterial blood pressure by renin-angiotensin Deleted DEFINITION The process by which renin-angiotensin modulates the force with which blood passes through the circulatory system.
2010-11-18 GO:0010362 negative regulation of anion channel activity by blue light Deleted DEFINITION Any process by which the blue light stops, prevents or reduces the frequency, rate, or extent of the anion channel activity.
2010-11-18 GO:0002257 negative regulation of kinin cascade Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate, or extent of the kinin cascade.
2010-11-18 GO:0003112 positive regulation of heart rate by neuronal epinephrine Deleted DEFINITION The process by which the secretion of epinephrine from nerve endings increases the rate of heart muscle contraction.
2010-11-18 GO:0002489 antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent Deleted DEFINITION The process by which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC class Ib protein complex following intracellular transport via a TAP (transporter associated with antigen processing) pathway. The peptide is typically a fragment of a larger endogenous protein which has been degraded within the cell and is dependent on TAP transport from the cytosol to ER for association with the MHC class Ib molecule. Class Ib here refers to non-classical class I molecules, such as those of the HLA-E gene family.
2010-11-18 GO:0003109 positive regulation of the force of heart contraction by circulating norepinephrine Deleted DEFINITION The process by which the secretion of norepinephrine into the bloodstream modulates the force of heart muscle contraction.
2010-11-18 GO:0003038 detection of reduced oxygen by aortic body chemoreceptor signaling Deleted DEFINITION The process by which information about the levels of oxygen are received and are converted to a molecular signal by chemoreceptors in an aortic body.
2010-11-18 GO:2000207 negative regulation of ribosomal small subunit export from nucleus Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of ribosomal small subunit export from nucleus.
2010-11-18 GO:0003143 embryonic heart tube morphogenesis Deleted DEFINITION The process by which the anatomical structures of the embryonic heart tube are generated and organized. Morphogenesis pertains to the creation of form. The embryonic heart tube is an epithelial tube that will give rise to the mature heart.
2010-11-18 GO:0003001 generation of a signal involved in cell-cell signaling Deleted DEFINITION The cellular process by which a physical entity or change in state, a signal, is created that originates in one cell and is used to transfer information to another cell. This process begins with the initial formation of the signal and ends with the mature form and placement of the signal.
2010-11-18 GO:0003106 negative regulation of glomerular filtration by angiotensin Deleted DEFINITION The process by which angiotensin directly decreases the rate of glomerular filtration in the kidney. Glomerular filtration is the processs whereby blood is filtered by the glomerulus into the renal tubule.
2010-11-18 GO:0002486 antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent Deleted DEFINITION The process by which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC class I protein complex following intracellular transport via a TAP-independent ER pathway. The peptide is typically a fragment of a larger endogenous protein which has been degraded within the cell and becomes associated with the MHC class I molecule in the ER following transport from the cytosol via a TAP-independent pathway. Class I here refers to classical class I molecules.
2010-11-18 GO:2000168 negative regulation of planar cell polarity pathway involved in neural tube closure Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of planar cell polarity pathway involved in neural tube closure.
2010-11-18 GO:2000239 negative regulation of tRNA export from nucleus Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of tRNA export from nucleus.
2010-11-18 GO:0003006 developmental process involved in reproduction Deleted DEFINITION A developmental process by which a progressive change in the state of some part of an organism specifically contributes to its ability to form offspring.
2010-11-18 GO:0002471 monocyte antigen processing and presentation Deleted DEFINITION The process by which a monocyte expresses antigen (peptide or lipid) on its cell surface in association with an MHC protein complex.
2010-11-18 GO:0033004 negative regulation of mast cell activation Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate, or extent of mast cell activation.
2010-11-18 GO:2000154 negative regulation of flagellar cell motility Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of flagellar cell motility.
2010-11-18 GO:0002350 peripheral B cell positive selection Deleted DEFINITION Any process leading to positive selection of B cells in the periphery. Positive selection is the process by which B or T cells are selected to survive based on signaling through their antigen receptors.
2010-11-18 GO:0017014 protein nitrosylation Deleted DEFINITION The addition of a nitrosyl group to a protein amino acid.
2010-11-18 GO:2000242 negative regulation of reproductive process Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of reproductive process.
2010-11-18 GO:0002477 antigen processing and presentation of exogenous peptide antigen via MHC class Ib Deleted DEFINITION The process by which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class Ib protein complex. The peptide is typically a fragment of a larger exogenous protein which has been degraded within the cell. Class Ib here refers to non-classical class I molecules, such as those of the HLA-E gene family.
2010-11-18 GO:0061369 negative regulation of testicular blood vessel morphogenesis Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of blood vessel morphogenesis in the testicle.
2010-11-18 GO:0003064 regulation of heart rate by hormone Deleted DEFINITION The process by which the hormones modulates the rate of heart muscle contraction. A hormone is one of a group of substances formed in very small amounts in one specialized organ or group of cells and carried (sometimes in the bloodstream) to another organ or group of cells, in the same organism, upon which they have a specific regulatory action.
2010-11-18 GO:0003022 detection of pH by chemoreceptor signaling Deleted DEFINITION The process by which information about the levels of hydrogen ions are received and are converted to a molecular signal by chemoreceptors in the carotid bodies and the aortic bodies.
2010-11-18 GO:0003067 circadian regulation of systemic arterial blood pressure by hormone Deleted DEFINITION The process by which hormones modulate the force with which blood passes through the circulatory system contributing to different values of blood pressure oscillating with a regularity of approximately 24 hours. A hormone is one of a group of substances formed in very small amounts in one specialized organ or group of cells and carried (sometimes in the bloodstream) to another organ or group of cells, in the same organism, upon which they have a specific regulatory action.
2010-11-18 GO:0003095 pressure natriuresis Deleted DEFINITION The process by which the volume of blood increases renal pressure and results in an increase in natriuresis and diuresis.
2010-11-18 GO:0002472 macrophage antigen processing and presentation Deleted DEFINITION The process by which a macrophage expresses antigen (peptide or lipid) on its cell surface in association with an MHC protein complex.
2010-11-18 GO:0003041 excitation of vasomotor center by carotid body chemoreceptor signaling Deleted DEFINITION The process by which the molecular signal from a carotid body is relayed to the vasomotor center, causing it to signal an increase arterial pressure.
2010-11-18 GO:0002562 somatic diversification of immune receptors via germline recombination within a single locus Deleted DEFINITION The process by which immune receptor genes are diversified through recombination of the germline genetic elements within a single genetic locus.
2010-11-18 GO:0003142 cardiogenic plate morphogenesis Deleted DEFINITION The process by which the anatomical structures of the cardiogenic plate are generated and organized. The cardiogenic plate is the first recognizable structure derived from the heart field.
2010-11-18 GO:2000250 negative regulation of actin cytoskeleton reorganization Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of actin cytoskeleton reorganization.
2010-11-18 GO:0003151 outflow tract morphogenesis Deleted DEFINITION The process by which the anatomical structures of the outflow tract are generated and organized. Morphogenesis pertains to the creation of form. The outflow tract is the portion of the heart through which blood flows into the arteries.
2010-11-18 GO:0002480 antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent Deleted DEFINITION The process by which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class I protein complex following intracellular transport via a pathway not requiring TAP (transporter associated with antigen processing). The peptide is typically a fragment of a larger exogenous protein which has been degraded within the cell. Class I here refers to classical class I molecules.
2010-11-18 GO:2000225 negative regulation of testosterone biosynthetic process Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of testosterone biosynthetic process.
2010-11-18 GO:0002470 plasmacytoid dendritic cell antigen processing and presentation Deleted DEFINITION The process by which a plasmacytoid dendritic cell expresses antigen (peptide or lipid) on its cell surface in association with an MHC protein complex.
2010-11-18 GO:0002566 somatic diversification of immune receptors via somatic mutation Deleted DEFINITION The process by which immune receptor genes are diversified through somatic mutation.
2010-11-18 GO:0003082 positive regulation of renal output by angiotensin Deleted DEFINITION Any process by which angiotensin directly increases the rate of natriuresis and diuresis in the kidney.
2010-11-18 GO:2000190 negative regulation of regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor.
2010-11-18 GO:0002365 gamma-delta T cell lineage commitment Deleted DEFINITION The process by which a pro-T cell becomes committed to becoming a gamma-delta T cell.
2010-11-18 GO:0002346 B cell positive selection Deleted DEFINITION Any process by which B cells are selected to survive based on signaling through the B cell antigen receptor.
2010-11-18 GO:0003021 detection of increased carbon dioxide by chemoreceptor signaling Deleted DEFINITION The process by which information about the levels of carbon dioxideare received and are converted to a molecular signal by chemoreceptors in the carotid bodies and the aortic bodies.
2010-11-18 GO:0002363 alpha-beta T cell lineage commitment Deleted DEFINITION The process by which a pro-T cell becomes committed to becoming an alpha-beta T cell.
2010-11-18 GO:0018119 peptidyl-cysteine S-nitrosylation Deleted DEFINITION The S-nitrosylation of peptidyl-cysteine to form peptidyl-S-nitrosyl-L-cysteine.
2010-11-18 GO:2000227 negative regulation of pancreatic A cell differentiation Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of pancreatic A cell differentiation.
2010-11-18 GO:2000151 negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis.
2010-11-18 GO:0035606 peptidyl-cysteine S-trans-nitrosylation Added DEFINITION Transfer of a nitric oxide (NO) group from one cysteine residue to another.
2010-11-18 GO:0043371 negative regulation of CD4-positive, alpha-beta T cell differentiation Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate, or extent of CD4-positive, alpha beta T cell differentiation.
2010-11-18 GO:0072358 cardiovascular system development Added DEFINITION The process whose specific outcome is the progression of the cardiovascular system over time, from its formation to the mature structure. The cardiovascular system is the anatomical system that has as its parts the heart and blood vessels.
2010-11-18 GO:0072364 regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter Added DEFINITION Any process that modulates the frequency, rate or extent of a cellular ketone metabolic process by modulating the frequency, rate or extent of transcription from an RNA polymerase II promoter.
2010-11-18 GO:0072367 regulation of lipid transport by regulation of transcription from RNA polymerase II promoter Added DEFINITION Any process that modulates the frequency, rate or extent of lipid transport by modulating the frequency, rate or extent of transcription from an RNA polymerase II promoter.
2010-11-18 GO:2000186 negative regulation of phosphate transmembrane transport Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of phosphate transmembrane transport.
2010-11-18 GO:0018230 peptidyl-L-cysteine S-palmitoylation Deleted DEFINITION The palmitoylation of peptidyl-serine to form peptidyl-S-palmitoyl-L-cysteine; the palmitate group represents a mixture of saturated and unsaturated fatty acids.
2010-11-18 GO:0016445 somatic diversification of immunoglobulins Deleted DEFINITION The somatic process by means of which sequence diversity of immunoglobulins is generated.
2010-11-18 GO:0003066 positive regulation of heart rate by norepinephrine Deleted DEFINITION The process by which the secretion of norepinephrine into the bloodstream or released from nerve endings increases the rate of heart muscle contraction.
2010-11-18 GO:0002680 pro-T cell lineage commitment Deleted DEFINITION The process by which a lymphoid progenitor cell becomes committed to becoming a pro-T cell.
2010-11-18 GO:0003160 endocardium morphogenesis Deleted DEFINITION The process by which the anatomical structure of the endocardium is generated and organized. The endocardium is an anatomical structure comprised of an endothelium and an extracellular matrix that forms the innermost layer of tissue of the heart, and lines the heart chambers.
2010-11-18 GO:0002469 myeloid dendritic cell antigen processing and presentation Deleted DEFINITION The process by which a myeloid dendritic cell expresses antigen (peptide or lipid) on its cell surface in association with an MHC protein complex.
2010-11-18 GO:0002344 B cell affinity maturation Deleted DEFINITION The process by which B cells produce antibodies with increased antigen affinity. This is accomplished by somatic hypermutation and selection for B cells which produce higher affinity antibodies to antigen.
2010-11-18 GO:0002487 antigen processing and presentation of endogenous peptide antigen via MHC class I via endolysosomal pathway Deleted DEFINITION The process by which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC class I protein complex. The peptide is typically a fragment of a larger endogenous protein which has been degraded within the cell and becomes associated with the MHC class I molecule in an endolysosome. Class I here refers to classical class I molecules.
2010-11-18 GO:0002476 antigen processing and presentation of endogenous peptide antigen via MHC class Ib Deleted DEFINITION The process by which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC class Ib protein complex. The peptide is typically a fragment of a larger endogenous protein which has been degraded within the cell. Class Ib here refers to non-classical class I molecules, such as those of the HLA-E gene family.
2010-11-18 GO:0003114 positive regulation of heart rate by circulating norepinephrine Deleted DEFINITION The process by which the secretion of norepinephrine into the bloodstream increases the rate of heart muscle contraction.
2010-11-18 GO:2000166 negative regulation of planar cell polarity pathway involved in pericardium morphogenesis Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of planar cell polarity pathway involved in pericardium morphogenesis.
2010-11-18 GO:2000181 negative regulation of blood vessel morphogenesis Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of blood vessel morphogenesis.
2010-11-18 GO:0003113 positive regulation of heart rate by neuronal norepinephrine Deleted DEFINITION The process by which the secretion of norepinephrine released from nerve endings increases the rate of heart muscle contraction.
2010-11-18 GO:0002549 negative regulation of plasma kallikrein-kinin cascade Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate, or extent of the plasma kallikrein-kinin cascade.
2010-11-18 GO:0034119 negative regulation of erythrocyte aggregation Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate, or extent of erythrocyte aggregation.
2010-11-18 GO:0002207 gene conversion of immunoglobulin genes involved in immune response Deleted DEFINITION The somatic process by which immunoglobulin genes are diversified through the mechanism of gene conversion following the induction of and contributing to an immune response.
2010-11-18 GO:2000233 negative regulation of rRNA processing Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of rRNA processing.
2010-11-18 GO:2000215 negative regulation of proline metabolic process Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of proline metabolic process.
2010-11-18 GO:2000171 negative regulation of dendrite development Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of dendrite development.
2010-11-18 GO:0003007 heart morphogenesis Deleted DEFINITION The developmental process by which the heart is generated and organized. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood.
2010-11-18 GO:0003004 follicular fluid formation in ovarian follicle antrum involved in distinct antral spaces stage Deleted DEFINITION The menstrual cycle process by which one central cavity separating the oocyte/cumulus complex from mural granulosa and theca cells is formed as part of the antral spaces stage of oogenesis.
2010-11-18 GO:2000149 negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of planar cell polarity pathway involved in ventricular septum morphogenesis.
2010-11-18 GO:0003101 regulation of systemic arterial blood pressure by circulatory epinephrine-norepinephrine Deleted DEFINITION The process by which epinephrine-norepinephrine modulate the force with which blood passes through the circulatory system.
2010-11-18 GO:0002360 T cell lineage commitment Deleted DEFINITION The process by which a lymphoid progenitor cell becomes committed to becoming any type of T cell.
2010-11-18 GO:0003036 detection of pH by aortic body chemoreceptor signaling Deleted DEFINITION The process by which information about the levels of hydrogen ions are received and are converted to a molecular signal by chemoreceptors in an aortic body.
2010-11-18 GO:0003003 follicular fluid formation in ovarian follicle antrum involved in fused antrum stage Deleted DEFINITION The ovulation cycle process by which one central cavity separating the oocyte/cumulus complex from mural granulosa and theca cells is formed as part of the fused antrum stage of oogenesis.
2010-11-18 GO:0003035 detection of increased carbon dioxide by carotid body chemoreceptor signaling Deleted DEFINITION The process by which information about the levels of carbon dioxideare received and are converted to a molecular signal by chemoreceptors in a carotid body.
2010-11-18 GO:0003107 positive regulation of natriuresis by angiotensin Deleted DEFINITION The process by which angiotensin increases the rate of natriuresis indirectly via diuresis. Natriuresis is the process of renal sodium excretion.
2010-11-18 GO:0003100 regulation of systemic arterial blood pressure by endothelin Deleted DEFINITION The process by which endothelin modulates the force with which blood passes through the circulatory system. Endothelin is a hormone that is released by the endothelium, and it is a vasoconstrictor.
2010-11-18 GO:0033629 negative regulation of cell adhesion mediated by integrin Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate, or extent of cell adhesion mediated by integrin.
2010-11-18 GO:0002681 somatic recombination of T cell receptor gene segments Deleted DEFINITION The process by which T cell receptor genes are formed through recombination of the germline genetic elements, also known as T cell receptor gene segments.
2010-11-18 GO:0002206 gene conversion of immunoglobulin genes Deleted DEFINITION The somatic process by which immunoglobulin genes are diversified through the mechanism of gene conversion.
2010-11-18 GO:0002491 antigen processing and presentation of endogenous peptide antigen via MHC class II Deleted DEFINITION The process by which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC class II protein complex. The peptide antigen is typically, but not always, processed from a whole protein.
2010-11-18 GO:0002348 central B cell positive selection Deleted DEFINITION Any process leading to positive selection of B cells in the bone marrow. Positive selection is the process by which B or T cells are selected to survive based on signaling through their antigen receptors.
2010-11-18 GO:2000212 negative regulation of glutamate metabolic process Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of glutamate metabolic process.
2010-11-18 GO:0000769 syncytium formation by mitosis without cytokinesis Deleted DEFINITION The formation of a syncytium, a mass of cytoplasm containing several nuclei enclosed within a single plasma membrane, by one or more rounds of nuclear division without cell division.
2010-11-18 GO:0002474 antigen processing and presentation of peptide antigen via MHC class I Deleted DEFINITION The process by which an antigen-presenting cell expresses a peptide antigen on its cell surface in association with an MHC class I protein complex. Class I here refers to classical class I molecules.
2010-11-18 GO:0002495 antigen processing and presentation of peptide antigen via MHC class II Deleted DEFINITION The process by which an antigen-presenting cell expresses a peptide antigen on its cell surface in association with an MHC class II protein complex. The peptide antigen is typically, but not always, processed from a whole protein.
2010-11-18 GO:0002482 antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-independent Deleted DEFINITION The process by which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class Ib protein complex following intracellular transport via a pathway not requiring TAP (transporter associated with antigen processing). The peptide is typically a fragment of a larger exogenous protein which has been degraded within the cell. Class Ib here refers to non-classical class I molecules, such as those of the HLA-E gene family.
2010-11-18 GO:2000245 negative regulation of FtsZ-dependent cytokinesis Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of cytokinesis by binary fission.
2010-11-18 GO:0002336 B-1 B cell lineage commitment Deleted DEFINITION The process by which an immature B cell becomes committed to become a B-1 B cell.
2010-11-18 GO:0000769 syncytium formation by mitosis without cytokinesis Added DEFINITION The formation of a syncytium, a mass of cytoplasm containing several nuclei enclosed within a single plasma membrane, by one or more rounds of nuclear division without cytokinesis.
2010-11-18 GO:0001945 lymph vessel development Added DEFINITION The process whose specific outcome is the progression of a lymph vessel over time, from its formation to the mature structure.
2010-11-18 GO:0002257 negative regulation of kinin cascade Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate, or extent of the kinin cascade.
2010-11-18 GO:0002467 germinal center formation Added DEFINITION The process in which germinal centers form. A germinal center is a specialized microenvironment formed when activated B cells enter lymphoid follicles. Germinal centers are the foci for B cell proliferation and somatic hypermutation.
2010-11-18 GO:0002474 antigen processing and presentation of peptide antigen via MHC class I Added DEFINITION The process in which an antigen-presenting cell expresses a peptide antigen on its cell surface in association with an MHC class I protein complex. Class I here refers to classical class I molecules.
2010-11-18 GO:0002477 antigen processing and presentation of exogenous peptide antigen via MHC class Ib Added DEFINITION The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class Ib protein complex. The peptide is typically a fragment of a larger exogenous protein which has been degraded within the cell. Class Ib here refers to non-classical class I molecules, such as those of the HLA-E gene family.
2010-11-18 GO:0002479 antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent Added DEFINITION The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class I protein complex following intracellular transport via a TAP (transporter associated with antigen processing) pathway. The peptide is typically a fragment of a larger exogenous protein which has been degraded within the cell and is dependent on TAP transport from the cytosol to ER for association with the MHC class I molecule. Class I here refers to classical class I molecules.
2010-11-18 GO:0002482 antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-independent Added DEFINITION The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class Ib protein complex following intracellular transport via a pathway not requiring TAP (transporter associated with antigen processing). The peptide is typically a fragment of a larger exogenous protein which has been degraded within the cell. Class Ib here refers to non-classical class I molecules, such as those of the HLA-E gene family.
2010-11-18 GO:0002483 antigen processing and presentation of endogenous peptide antigen Added DEFINITION The process in which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC protein complex. The peptide is typically a fragment of a larger endogenous protein which has been degraded within the cell.
2010-11-18 GO:0002546 negative regulation of tissue kallikrein-kinin cascade Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate, or extent of the tissue kallikrein-kinin cascade.
2010-11-18 GO:0002568 somatic diversification of T cell receptor genes Added DEFINITION The somatic process that results in the generation of sequence diversity of T cell receptor genes.
2010-11-18 GO:0061369 negative regulation of testicular blood vessel morphogenesis Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of blood vessel morphogenesis in the testicle.
2010-11-18 GO:0072360 vascular cord development Added DEFINITION The progression of the vascular cord over time from its initial formation until its mature state. The vascular cord is the primordial vasculature that will develop into blood vessels by the process of tubulogenesis.
2010-11-18 GO:0072361 regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter Added DEFINITION Any process that modulates the frequency, rate or extent of glycolysis by modulating the frequency, rate or extent of transcription from an RNA polymerase II promoter.
2010-11-18 GO:0072366 regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter Added DEFINITION Any process that modulates the frequency, rate or extent of a cellular ketone metabolic process by activating or increasing the frequency, rate or extent of transcription from an RNA polymerase II promoter.
2010-11-18 GO:0072370 histone H2A-S121 phosphorylation Added DEFINITION The modification of histone H2A by the addition of an phosphate group to a serine residue at position 121 of the histone.
2010-11-18 GO:2000160 negative regulation of planar cell polarity pathway involved in heart morphogenesis Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of planar cell polarity pathway involved in heart morphogenesis.
2010-11-18 GO:0003152 morphogenesis of an epithelial fold involved in embryonic heart tube formation Deleted DEFINITION The morphogenetic process by which an epithelial sheet bends along a linear axis that contributes to embryonic heart tube formation.
2010-11-18 GO:2000146 negative regulation of cell motility Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of cell motility.
2010-11-18 GO:0003019 central nervous system control of baroreceptor feedback Deleted DEFINITION The neurological process by which nerve impulses arising in the aorta or the carotid sinuses travel to the medulla and reach the nucleus of tractus solaris.
2010-11-18 GO:2000221 negative regulation of pseudohyphal growth Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of pseudohyphal growth.
2010-11-18 GO:0003059 positive regulation of the force of heart contraction by epinephrine Deleted DEFINITION The process by which the secretion of epinephrine into the bloodstream or released from nerve endings modulates the force of heart muscle contraction.
2010-11-18 GO:0002472 macrophage antigen processing and presentation Added DEFINITION The process in which a macrophage expresses antigen (peptide or lipid) on its cell surface in association with an MHC protein complex.
2010-11-18 GO:0002473 non-professional antigen presenting cell antigen processing and presentation Added DEFINITION The process in which a non-professional antigen presenting cell expresses antigen (peptide or lipid) on its cell surface in association with an MHC protein complex. Non-professional antigen presenting cells include all cell types but dendritic cells, B cells, T cells, monocytes, macrophages, and neutrophils.
2010-11-18 GO:0002475 antigen processing and presentation via MHC class Ib Added DEFINITION The process in which an antigen-presenting cell expresses antigen (peptide or lipid) on its cell surface in association with an MHC class Ib protein complex. Class Ib here refers to non-classical class I molecules, such as those of the CD1 or HLA-E gene families.
2010-11-18 GO:0002505 antigen processing and presentation of polysaccharide antigen via MHC class II Added DEFINITION The process in which an antigen-presenting cell expresses a polysaccharide antigen on its cell surface in association with an MHC class II protein complex.
2010-11-18 GO:0002549 negative regulation of plasma kallikrein-kinin cascade Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate, or extent of the plasma kallikrein-kinin cascade.
2010-11-18 GO:0002565 somatic diversification of immune receptors via gene conversion Added DEFINITION The process in which immune receptor genes are diversified through gene conversion.
2010-11-18 GO:0003039 detection of reduced oxygen by carotid body chemoreceptor signaling Added DEFINITION The process in which information about the levels of oxygen are received and are converted to a molecular signal by chemoreceptors in a carotid body.
2010-11-18 GO:0003052 circadian regulation of systemic arterial blood pressure Added DEFINITION Any process in which an organism modulates its blood pressure at different values with a regularity of approximately 24 hours.
2010-11-18 GO:0003110 positive regulation of the force of heart contraction by neuronal norepinephrine Deleted DEFINITION The process by which the release of norepinephrine from nerve endings modulates the force of heart muscle contraction.
2010-11-18 GO:0002484 antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway Deleted DEFINITION The process by which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC class I protein complex following intracellular transport via an ER pathway. The peptide is typically a fragment of a larger endogenous protein which has been degraded within the cell and becomes associated with the MHC class I molecule in the ER. Class I here refers to classical class I molecules.
2010-11-18 GO:0002202 somatic diversification of variable lymphocyte receptors of jawless fish Deleted DEFINITION The somatic process by means of which sequence diversity of the variable lymphocyte receptors (VLR) of jawless fish is generated.
2010-11-18 GO:0002567 somatic diversification of FREP-based immune receptors Deleted DEFINITION The process by means of which sequence diversity of the FREP-based immune receptors of snails is generated.
2010-11-18 GO:0018009 N-terminal peptidyl-L-cysteine N-palmitoylation Deleted DEFINITION The palmitoylation of the N-terminal cysteine of proteins to form the derivative N-palmitoyl-L-cysteine.
2010-11-18 GO:0003087 positive regulation of the force of heart contraction by neuronal epinephrine Deleted DEFINITION The process by which the release of epinephrine from nerve endings modulates the force of heart muscle contraction.
2010-11-18 GO:0002481 antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent Deleted DEFINITION The process by which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class Ib protein complex following intracellular transport via a TAP (transporter associated with antigen processing) pathway. The peptide is typically a fragment of a larger exogenous protein which has been degraded within the cell and is dependent on TAP transport from the cytosol to ER for association with the MHC class Ib molecule. Class Ib here refers to non-classical class I molecules, such as those of the HLA-E gene family.
2010-11-18 GO:0033007 negative regulation of mast cell activation involved in immune response Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate, or extent of mast cell activation as part of an immune response.
2010-11-18 GO:0003053 circadian regulation of heart rate Deleted DEFINITION Any process by which an organism modulates its heart rate at different values with a regularity of approximately 24 hours.
2010-11-18 GO:0002457 T cell antigen processing and presentation Deleted DEFINITION The process by which a T cell expresses antigen (peptide or lipid) on its cell surface in association with an MHC protein complex.
2010-11-18 GO:0003060 negative regulation of the force of heart contraction by acetylcholine Deleted DEFINITION The process by which acetylcholine released from vagus nerve endings binds to muscarinic receptors and decreases the force of heart muscle contraction.
2010-11-18 GO:0002364 NK T cell lineage commitment Deleted DEFINITION The process by which a pro-T cell becomes committed to becoming an NK T cell.
2010-11-18 GO:0002128 tRNA nucleoside ribose methylation Deleted DEFINITION The process by which the sugar of a nucleoside in tRNA is modified at the 2'O position.
2010-11-18 GO:2000183 negative regulation of progesterone biosynthetic process Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of progesterone biosynthetic process.
2010-11-18 GO:0003033 detection of hypoxic conditions in blood by aortic body chemoreceptor signaling Deleted DEFINITION The process by which information about a lack of oxygen are received and are converted to a molecular signal by chemoreceptors in the aortic bodies.
2010-11-18 GO:0002478 antigen processing and presentation of exogenous peptide antigen Deleted DEFINITION The process by which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC protein complex. The peptide is typically a fragment of a larger exogenous protein which has been degraded within the cell.
2010-11-18 GO:0043371 negative regulation of CD4-positive, alpha-beta T cell differentiation Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate, or extent of CD4-positive, alpha beta T cell differentiation.
2010-11-18 GO:0033624 negative regulation of integrin activation Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate, or extent of integrin activation.
2010-11-18 GO:0002505 antigen processing and presentation of polysaccharide antigen via MHC class II Deleted DEFINITION The process by which an antigen-presenting cell expresses a polysaccharide antigen on its cell surface in association with an MHC class II protein complex.
2010-11-18 GO:0003055 circadian regulation of heart rate by the suprachiasmatic nucleus Deleted DEFINITION The process by which the suprachiasmatic nucleus modulates heart rate at different values with a regularity of approximately 24 hours.
2010-11-18 GO:0003088 positive regulation of the force of heart contraction by circulating epinephrine Deleted DEFINITION The process by which the secretion of epinephrine into the bloodstream modulates the force of heart muscle contraction.
2010-11-18 GO:0002467 germinal center formation Deleted DEFINITION The process by which germinal centers form. A germinal center is a specialized microenvironment formed when activated B cells enter lymphoid follicles. Germinal centers are the foci for B cell proliferation and somatic hypermutation.
2010-11-18 GO:0003058 hormonal regulation of the force of heart contraction Deleted DEFINITION The process by which the hormones modulates the force of heart muscle contraction. A hormone is one of a group of substances formed in very small amounts in one specialized organ or group of cells and carried (sometimes in the bloodstream) to another organ or group of cells, in the same organism, upon which they have a specific regulatory action.
2010-11-18 GO:0001929 negative regulation of exocyst assembly Deleted DEFINITION Any process that stops, prevents or reduces the rate or extent of exocyst assembly.
2010-11-18 GO:0003069 vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure Deleted DEFINITION The process by which acetylcholine signaling causes vasodilation, resulting in a change in blood pressure.
2010-11-18 GO:2000218 negative regulation of invasive growth in response to glucose limitation Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of invasive growth in response to glucose limitation.
2010-11-18 GO:0010360 negative regulation of anion channel activity Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate, or extent of the anion channel activity.
2010-11-18 GO:0007059 chromosome segregation Deleted DEFINITION The process by which genetic material, in the form of chromosomes, is organized into specific structures and then physically separated and apportioned to two or more sets. Chromosome segregation begins with the alignment of chromosomes at the metaphase plate, includes chromosome separation, and ends when chromosomes have completed movement to the spindle poles.
2010-11-18 GO:0002473 non-professional antigen presenting cell antigen processing and presentation Deleted DEFINITION The process by which a non-professional antigen presenting cell expresses antigen (peptide or lipid) on its cell surface in association with an MHC protein complex. Non-professional antigen presenting cells include all cell types but dendritic cells, B cells, T cells, monocytes, macrophages, and neutrophils.
2010-11-18 GO:0001933 negative regulation of protein phosphorylation Deleted DEFINITION Any process that stops, prevents or decreases the rate of addition of phosphate groups to amino acids within a protein.
2010-11-18 GO:0034107 negative regulation of erythrocyte clearance Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate, or extent of erythrocyte clearance.
2010-11-18 GO:2000195 negative regulation of female gonad development Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of female gonad development.
2010-11-18 GO:2000218 negative regulation of invasive growth in response to glucose limitation Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of invasive growth in response to glucose limitation.
2010-11-18 GO:2000230 negative regulation of pancreatic stellate cell proliferation Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of pancreatic stellate cell proliferation.
2010-11-18 GO:0001933 negative regulation of protein phosphorylation Added DEFINITION Any process that stops, prevents or reduces the rate of addition of phosphate groups to amino acids within a protein.
2010-11-18 GO:0002346 B cell positive selection Added DEFINITION Any process in which B cells are selected to survive based on signaling through the B cell antigen receptor.
2010-11-18 GO:0002348 central B cell positive selection Added DEFINITION Any process leading to positive selection of B cells in the bone marrow. Positive selection is the process in which B or T cells are selected to survive based on signaling through their antigen receptors.
2010-11-18 GO:0002469 myeloid dendritic cell antigen processing and presentation Added DEFINITION The process in which a myeloid dendritic cell expresses antigen (peptide or lipid) on its cell surface in association with an MHC protein complex.
2010-11-18 GO:0002562 somatic diversification of immune receptors via germline recombination within a single locus Added DEFINITION The process in which immune receptor genes are diversified through recombination of the germline genetic elements within a single genetic locus.
2010-11-18 GO:0003005 follicular fluid formation in ovarian follicle antrum involved in scattered antral spaces stage Added DEFINITION The menstrual cycle process in which one central cavity separating the oocyte/cumulus complex from mural granulosa and theca cells is formed as part of the scattered antral spaces stage of oogenesis.
2010-11-18 GO:0003033 detection of hypoxic conditions in blood by aortic body chemoreceptor signaling Added DEFINITION The process in which information about a lack of oxygen are received and are converted to a molecular signal by chemoreceptors in the aortic bodies.
2010-11-18 GO:0003151 outflow tract morphogenesis Added DEFINITION The process in which the anatomical structures of the outflow tract are generated and organized. Morphogenesis pertains to the creation of form. The outflow tract is the portion of the heart through which blood flows into the arteries.
2010-11-18 GO:0003160 endocardium morphogenesis Added DEFINITION The process in which the anatomical structure of the endocardium is generated and organized. The endocardium is an anatomical structure comprised of an endothelium and an extracellular matrix that forms the innermost layer of tissue of the heart, and lines the heart chambers.
2010-11-18 GO:0016445 somatic diversification of immunoglobulins Added DEFINITION The somatic process that results in the generation of sequence diversity of immunoglobulins.
2010-11-18 GO:0072365 regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter Added DEFINITION Any process that modulates the frequency, rate or extent of a cellular ketone metabolic process by stopping, preventing, or reducing the frequency, rate or extent of transcription from an RNA polymerase II promoter.
2010-11-18 GO:0003001 generation of a signal involved in cell-cell signaling Added DEFINITION The cellular process that creates a physical entity or change in state, i.e. a signal, that originates in one cell and is used to transfer information to another cell. This process begins with the initial formation of the signal and ends with the mature form and placement of the signal.
2010-11-18 GO:0003006 developmental process involved in reproduction Added DEFINITION A developmental process in which a progressive change in the state of some part of an organism specifically contributes to its ability to form offspring.
2010-11-18 GO:0003055 circadian regulation of heart rate by the suprachiasmatic nucleus Added DEFINITION The process in which the suprachiasmatic nucleus modulates heart rate at different values with a regularity of approximately 24 hours.
2010-11-18 GO:0003086 regulation of systemic arterial blood pressure by local renal renin-angiotensin Added DEFINITION The process in which angiotensinogen metabolites in the kidney modulate the force with which blood passes through the renal circulatory system. The process begins when renin cleaves angiotensinogen.
2010-11-18 GO:0003095 pressure natriuresis Added DEFINITION The process in which the volume of blood increases renal pressure and results in an increase in natriuresis and diuresis.
2010-11-18 GO:0003106 negative regulation of glomerular filtration by angiotensin Added DEFINITION The process in which angiotensin directly decreases the rate of glomerular filtration in the kidney. Glomerular filtration is the processs whereby blood is filtered by the glomerulus into the renal tubule.
2010-11-18 GO:0001953 negative regulation of cell-matrix adhesion Deleted DEFINITION Any process that stops, prevents or reduces the rate or extent of cell adhesion to the extracellular matrix.
2010-11-18 GO:0018221 peptidyl-serine palmitoylation Deleted DEFINITION The palmitoylation of peptidyl-serine to form peptidyl-O-palmitoyl-L-threonine.
2010-11-18 GO:2000192 negative regulation of fatty acid transport Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of fatty acid transport.
2010-11-18 GO:0002201 somatic diversification of DSCAM-based immune receptors Deleted DEFINITION The somatic process by means of which sequence diversity of the DSCAM-based immune receptors of insects is generated.
2010-11-18 GO:2000140 negative regulation of octopamine signaling pathway involved in response to food Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of octopamine signaling pathway involved in response to food.
2010-11-18 GO:0010360 negative regulation of anion channel activity Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate, or extent of the anion channel activity.
2010-11-18 GO:0010362 negative regulation of anion channel activity by blue light Added DEFINITION Any process by which blue light stops, prevents, or reduces the frequency, rate, or extent of the anion channel activity.
2010-11-18 GO:0017014 protein nitrosylation Added DEFINITION The covalent addition of a nitric oxide group to an amino acid within a protein.
2010-11-18 GO:0018230 peptidyl-L-cysteine S-palmitoylation Added DEFINITION The covalent attachment of a palmitoyl group to a sulfur (S) atom within a cysteine residue to form peptidyl-S-palmitoyl-L-cysteine.
2010-11-18 GO:0033007 negative regulation of mast cell activation involved in immune response Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate, or extent of mast cell activation as part of an immune response.
2010-11-18 GO:0035605 peptidyl-cysteine S-nitrosylase activity Added DEFINITION Catalysis of the transfer of a nitric oxide (NO) group to a sulphur atom within a cysteine residue of a protein.
2010-11-18 GO:2000149 negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of planar cell polarity pathway involved in ventricular septum morphogenesis.
2010-11-18 GO:2000154 negative regulation of flagellar cell motility Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of flagellar cell motility.
2010-11-18 GO:2000166 negative regulation of planar cell polarity pathway involved in pericardium morphogenesis Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of planar cell polarity pathway involved in pericardium morphogenesis.
2010-11-18 GO:2000171 negative regulation of dendrite development Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of dendrite development.
2010-11-18 GO:2000175 negative regulation of pro-T cell differentiation Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of pro-T cell differentiation.
2010-11-18 GO:2000215 negative regulation of proline metabolic process Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of proline metabolic process.
2010-11-18 GO:0003002 regionalization Deleted DEFINITION The pattern specification process by which an axis or axes is subdivided in space to define an area or volume in which specific patterns of cell differentiation will take place or in which cells interpret a specific environment.
2010-11-18 GO:0003083 negative regulation of renal output by angiotensin Deleted DEFINITION The process by which angiotensin directly decreases the rate of natriuresis and diuresis in the kidney.
2010-11-18 GO:0034115 negative regulation of heterotypic cell-cell adhesion Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate, or extent of heterotypic cell-cell adhesion.
2010-11-18 GO:0003020 detection of reduced oxygen by chemoreceptor signaling Deleted DEFINITION The process by which information about the levels of oxygen are received and are converted to a molecular signal by chemoreceptors in the carotid bodies and the aortic bodies.
2010-11-18 GO:0003086 regulation of systemic arterial blood pressure by local renal renin-angiotensin Deleted DEFINITION The process by which angiotensinogen metabolites in the kidney modulate the force with which blood passes through the renal circulatory system. The process begins when renin cleaves angiotensinogen.
2010-11-18 GO:0003029 detection of hypoxic conditions in blood by carotid body chemoreceptor signaling Deleted DEFINITION The process by which information about a lack of oxygen are received and are converted to a molecular signal by chemoreceptors in the carotid bodies.
2010-11-18 GO:0001945 lymph vessel development Deleted DEFINITION The process whose specific outcome is the progression of the lymphatic vasculature over time, from its formation to the mature structure.
2010-11-18 GO:0034111 negative regulation of homotypic cell-cell adhesion Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate, or extent of homotypic cell-cell adhesion.
2010-11-18 GO:0002483 antigen processing and presentation of endogenous peptide antigen Deleted DEFINITION The process by which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC protein complex. The peptide is typically a fragment of a larger endogenous protein which has been degraded within the cell.
2010-11-18 GO:0003149 membranous septum morphogenesis Deleted DEFINITION The process by which the membranous septum is generated and organized. The membranous septum is the upper part of ventricular septum. Morphogenesis pertains to the creation of form.
2010-11-18 GO:0003063 negative regulation of heart rate by acetylcholine Deleted DEFINITION The process by which acetylcholine released from vagus nerve endings binds to muscarinic receptors on the pacemaker cells and decreases the rate of heart muscle contraction.
2010-11-18 GO:2000230 negative regulation of pancreatic stellate cell proliferation Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of pancreatic stellate cell proliferation.
2010-11-18 GO:0002208 somatic diversification of immunoglobulins involved in immune response Deleted DEFINITION The somatic process by means of which sequence diversity of immunoglobulins is generated after the induction and contributing to an immune response.
2010-11-18 GO:0003037 detection of pH by carotid body chemoreceptor signaling Deleted DEFINITION The process by which information about the levels of hydrogen ions are received and are converted to a molecular signal by chemoreceptors in a carotid body.
2010-11-18 GO:0033633 negative regulation of cell-cell adhesion mediated by integrin Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate, or extent of cell-cell adhesion mediated by integrin.
2010-11-18 GO:0003150 muscular septum morphogenesis Deleted DEFINITION The process by which the muscular septum is generated and organized. The muscular septum is the lower part of the ventricular septum.
2010-11-18 GO:2000160 negative regulation of planar cell polarity pathway involved in heart morphogenesis Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of planar cell polarity pathway involved in heart morphogenesis.
2010-11-18 GO:0002485 antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent Deleted DEFINITION The process by which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC class I protein complex following intracellular transport via a TAP-dependent ER pathway. The peptide is typically a fragment of a larger endogenous protein which has been degraded within the cell and becomes associated with the MHC class I molecule in the ER following TAP-dependent transport from the cytosol. Class I here refers to classical class I molecules.
2010-11-18 GO:0002504 antigen processing and presentation of peptide or polysaccharide antigen via MHC class II Deleted DEFINITION The process by which an antigen-presenting cell expresses antigen (peptide or polysaccharide) on its cell surface in association with an MHC class II protein complex.
2010-11-18 GO:2000164 negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of planar cell polarity pathway involved in outflow tract morphogenesis.
2010-11-18 GO:2000178 negative regulation of neural precursor cell proliferation Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of neural precursor cell proliferation.
2010-11-18 GO:0003005 follicular fluid formation in ovarian follicle antrum involved in scattered antral spaces stage Deleted DEFINITION The menstrual cycle process by which one central cavity separating the oocyte/cumulus complex from mural granulosa and theca cells is formed as part of the scattered antral spaces stage of oogenesis.
2010-11-18 GO:2000173 negative regulation of branching morphogenesis of a nerve Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of branching morphogenesis of a nerve.
2010-11-18 GO:0003034 detection of increased carbon dioxide by aortic body chemoreceptor signaling Deleted DEFINITION The process by which information about the levels of carbon dioxideare received and are converted to a molecular signal by chemoreceptors in an aortic body.
2010-11-18 GO:0003146 heart jogging Deleted DEFINITION The morphogenetic process by which the heart cone is displaced to the left with respect to the vector of the anterior-posterior axis.
2010-11-18 GO:2000143 negative regulation of DNA-templated transcription, initiation Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of transcription initiation.
2010-11-18 GO:0002490 antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-independent Deleted DEFINITION The process by which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC class Ib protein complex following intracellular transport via a pathway not requiring TAP (transporter associated with antigen processing). The peptide is typically a fragment of a larger endogenous protein which has been degraded within the cell. Class Ib here refers to non-classical class I molecules, such as those of the HLA-E gene family.
2010-11-18 GO:2000236 negative regulation of tRNA processing Deleted DEFINITION Any process that stops, prevents or reduces the frequency, rate or extent of tRNA processing.
2010-11-18 GO:0003040 excitation of vasomotor center by aortic body chemoreceptor signaling Deleted DEFINITION The process by which the molecular signal from an aortic body is relayed to the vasomotor center, causing it to signal an increase arterial pressure.
2010-11-18 GO:0003139 secondary heart field specification Deleted DEFINITION The process by which a specific region of the lateral mesoderm is delineated into the area which will form the majority of the mesodermal component of the right ventricle, arterial and venous poles.
2010-11-18 GO:0003148 outflow tract septum morphogenesis Deleted DEFINITION The process by which the anatomical structures of the outflow tract septum are generated and organized. Morphogenesis pertains to the creation of form. The outflow tract septum is a partition in the outflow tract.
2010-11-18 GO:0003053 circadian regulation of heart rate Added DEFINITION Any process in which an organism modulates its heart rate at different values with a regularity of approximately 24 hours.
2010-11-18 GO:0003054 circadian regulation of systemic arterial blood pressure by the suprachiasmatic nucleus Added DEFINITION The process in which the suprachiasmatic nucleus modulates blood pressure at different values with a regularity of approximately 24 hours.
2010-11-18 GO:0003060 negative regulation of the force of heart contraction by acetylcholine Added DEFINITION The process in which acetylcholine released from vagus nerve endings binds to muscarinic receptors and decreases the force of heart muscle contraction.
2010-11-18 GO:0003061 positive regulation of the force of heart contraction by norepinephrine Added DEFINITION The process in which the secretion of norepinephrine into the bloodstream or released from nerve endings modulates the force of heart musclecontraction.
2010-11-18 GO:0003063 negative regulation of heart rate by acetylcholine Added DEFINITION The process in which acetylcholine released from vagus nerve endings binds to muscarinic receptors on the pacemaker cells and decreases the rate of heart muscle contraction.
2010-11-18 GO:0003110 positive regulation of the force of heart contraction by neuronal norepinephrine Added DEFINITION The process in which the release of norepinephrine from nerve endings modulates the force of heart muscle contraction.
2010-11-18 GO:0003113 positive regulation of heart rate by neuronal norepinephrine Added DEFINITION The process in which the secretion of norepinephrine released from nerve endings increases the rate of heart muscle contraction.
2010-11-18 GO:0003114 positive regulation of heart rate by circulating norepinephrine Added DEFINITION The process in which the secretion of norepinephrine into the bloodstream increases the rate of heart muscle contraction.
2010-11-18 GO:0033004 negative regulation of mast cell activation Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate, or extent of mast cell activation.
2010-11-18 GO:0034107 negative regulation of erythrocyte clearance Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate, or extent of erythrocyte clearance.
2010-11-18 GO:0072359 circulatory system development Added DEFINITION The process whose specific outcome is the progression of the circulatory system over time, from its formation to the mature structure. The circulatory system is the organ system that passes nutrients (such as amino acids and electrolytes), gases, hormones, blood cells, etc. to and from cells in the body to help fight diseases and help stabilize body temperature and pH to maintain homeostasis.
2010-11-18 GO:2000140 negative regulation of octopamine signaling pathway involved in response to food Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of octopamine signaling pathway involved in response to food.
2010-11-18 GO:2000146 negative regulation of cell motility Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of cell motility.
2010-11-18 GO:2000151 negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis.
2010-11-18 GO:2000178 negative regulation of neural precursor cell proliferation Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of neural precursor cell proliferation.
2010-11-18 GO:2000180 negative regulation of androgen biosynthetic process Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of androgen biosynthetic process.
2010-11-18 GO:2000221 negative regulation of pseudohyphal growth Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of pseudohyphal growth.
2010-11-18 GO:2000248 negative regulation of establishment or maintenance of neuroblast polarity Added DEFINITION Any process that stops, prevents, or reduces the frequency, rate or extent of establishment or maintenance of neuroblast polarity.
2010-11-18 GO:0001944 vasculature development Added DEFINITION The process whose specific outcome is the progression of the vasculature over time, from its formation to the mature structure. The vasculature is an interconnected tubular multi-tissue structure that contains fluid that is actively transported around the organism.
2010-11-18 GO:0002336 B-1 B cell lineage commitment Added DEFINITION The process in which an immature B cell becomes committed to become a B-1 B cell.
2010-11-18 GO:0002362 CD4-positive, CD25-positive, alpha-beta regulatory T cell lineage commitment Added DEFINITION The process in which a CD4-positive, alpha-beta T cell becomes committed to becoming a CD4-positive, CD25-positive, alpha-beta regulatory T cell.
2010-11-18 GO:0018221 peptidyl-serine palmitoylation Added SYNONYM peptidyl-serine O-palmitoylation
2010-11-18 GO:0035605 peptidyl-cysteine S-nitrosylase activity Added SYNONYM protein nitrosylase activity
2010-11-18 GO:0000769 syncytium formation by mitosis without cytokinesis Added SYNONYM syncytium formation by mitosis without cell division
2010-11-18 GO:0018220 peptidyl-threonine palmitoylation Added SYNONYM peptidyl-threonine O-palmitoylation
2010-11-18 GO:0051456 attachment of spindle microtubules to kinetochore involved in meiotic sister chromatid segregation Added SYNONYM meiotic bipolar attachment
2010-11-18 GO:0001944 vasculature development Added SYNONYM vascular system development
2010-11-18 GO:0035606 peptidyl-cysteine S-trans-nitrosylation Added SYNONYM cysteine-to-cysteine transnitrosylation
2010-11-18 GO:0072370 histone H2A-S121 phosphorylation Added SYNONYM histone H2AS121 phosphorylation
2010-11-18 GO:0035607 fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development Added SYNONYM FGFR signaling pathway involved in orbitofrontal cortex development
2010-11-18 GO:0072371 histone kinase activity (H2A-S121 specific) Added SYNONYM histone-serine kinase activity (H2A-S121 specific)
2010-11-18 GO:0072371 histone kinase activity (H2A-S121 specific) Added SYNONYM histone serine kinase activity (H2A-S121 specific)
2010-11-18 GO:0035606 peptidyl-cysteine S-trans-nitrosylation Added SYNONYM cysteine to cysteine nitrosylation
2010-11-18 GO:0072364 regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter Added SYNONYM regulation of cellular ketone metabolism by regulation of transcription from an RNA polymerase II promoter
2010-11-18 GO:0072366 regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter Added SYNONYM regulation of cellular ketone metabolism by positive regulation of transcription from an RNA polymerase II promoter
2010-11-18 GO:0018119 peptidyl-cysteine S-nitrosylation Added SYNONYM protein S-nitrosylation
2010-11-18 GO:0018119 peptidyl-cysteine S-nitrosylation Added SYNONYM S-nitrosylation
2010-11-18 GO:0051315 attachment of spindle microtubules to kinetochore involved in mitotic sister chromatid segregation Added SYNONYM mitotic bipolar attachment
2010-11-18 GO:0035606 peptidyl-cysteine S-trans-nitrosylation Added SYNONYM S-transnitrosylation
2010-11-18 GO:0035605 peptidyl-cysteine S-nitrosylase activity Added SYNONYM S-nitrosylase activity
2010-11-18 GO:0035607 fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development Added SYNONYM fibroblast growth factor receptor signalling pathway involved in orbitofrontal cortex development
2010-11-18 GO:0072365 regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter Added SYNONYM regulation of cellular ketone metabolism by negative regulation of transcription from an RNA polymerase II promoter
2010-11-18 GO:0035606 peptidyl-cysteine S-trans-nitrosylation Added SYNONYM protein-to-protein transnitrosylation
2010-11-18 GO:0035607 fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development Added SYNONYM FGF receptor signaling pathway involved in orbitofrontal cortex development
2010-11-18 GO:0072370 histone H2A-S121 phosphorylation Added SYNONYM histone H2A phosphorylation at S121
2010-11-18 GO:0003139 secondary heart field specification Added DEFINITION The process that results in the deliniation of a specific region of the lateral mesoderm into the area which will form the majority of the mesodermal component of the right ventricle, arterial and venous poles.

Relationships

Timestamp GO ID GO Term Name Action Category Detail
2010-11-18 GO:0072364 regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter Added RELATION is a GO:0010565 (regulation of cellular ketone metabolic process)
2010-11-18 GO:0072364 regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter Added RELATION is a GO:0006357 (regulation of transcription from RNA polymerase II promoter)
2010-11-18 GO:0072365 regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter Added RELATION is a GO:0000122 (negative regulation of transcription from RNA polymerase II promoter)
2010-11-18 GO:0072365 regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter Added RELATION is a GO:0072364 (regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter)
2010-11-18 GO:0072366 regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter Added RELATION is a GO:0045944 (positive regulation of transcription from RNA polymerase II promoter)
2010-11-18 GO:0072366 regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter Added RELATION is a GO:0072364 (regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter)
2010-11-18 GO:0072358 cardiovascular system development Added RELATION is a GO:0048731 (system development)
2010-11-18 GO:0072367 regulation of lipid transport by regulation of transcription from RNA polymerase II promoter Added RELATION is a GO:0006357 (regulation of transcription from RNA polymerase II promoter)
2010-11-18 GO:0072367 regulation of lipid transport by regulation of transcription from RNA polymerase II promoter Added RELATION is a GO:0032368 (regulation of lipid transport)
2010-11-18 GO:0072368 regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter Added RELATION is a GO:0000122 (negative regulation of transcription from RNA polymerase II promoter)
2010-11-18 GO:0072368 regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter Added RELATION is a GO:0072367 (regulation of lipid transport by regulation of transcription from RNA polymerase II promoter)
2010-11-18 GO:0072369 regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter Added RELATION is a GO:0045944 (positive regulation of transcription from RNA polymerase II promoter)
2010-11-18 GO:0072369 regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter Added RELATION is a GO:0072367 (regulation of lipid transport by regulation of transcription from RNA polymerase II promoter)
2010-11-18 GO:0072370 histone H2A-S121 phosphorylation Added RELATION is a GO:0035404 (histone-serine phosphorylation)
2010-11-18 GO:0072371 histone kinase activity (H2A-S121 specific) Added RELATION is a GO:0035174 (histone serine kinase activity)
2010-11-18 GO:0072371 histone kinase activity (H2A-S121 specific) Added RELATION part of GO:0072370 (histone H2A-S121 phosphorylation)
2010-11-18 GO:0071999 extracellular polysaccharide catabolic process Added RELATION is a GO:0046379 (extracellular polysaccharide metabolic process)
2010-11-18 GO:0072358 cardiovascular system development Added RELATION part of GO:0072359 (circulatory system development)
2010-11-18 GO:0072359 circulatory system development Added RELATION is a GO:0048731 (system development)
2010-11-18 GO:0072360 vascular cord development Added RELATION part of GO:0072358 (cardiovascular system development)
2010-11-18 GO:0072360 vascular cord development Added RELATION is a GO:0048856 (anatomical structure development)
2010-11-18 GO:0072361 regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter Added RELATION is a GO:0006110 (regulation of glycolytic process)
2010-11-18 GO:0072361 regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter Added RELATION is a GO:0006357 (regulation of transcription from RNA polymerase II promoter)
2010-11-18 GO:0072362 regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter Added RELATION is a GO:0000122 (negative regulation of transcription from RNA polymerase II promoter)
2010-11-18 GO:0072362 regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter Added RELATION is a GO:0072361 (regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter)
2010-11-18 GO:0072363 regulation of glycolytic by positive regulation of transcription from RNA polymerase II promoter Added RELATION is a GO:0072361 (regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter)
2010-11-18 GO:0072363 regulation of glycolytic by positive regulation of transcription from RNA polymerase II promoter Added RELATION is a GO:0045944 (positive regulation of transcription from RNA polymerase II promoter)
2010-11-18 GO:0035605 peptidyl-cysteine S-nitrosylase activity Added RELATION is a GO:0016769 (transferase activity, transferring nitrogenous groups)
2010-11-18 GO:0035605 peptidyl-cysteine S-nitrosylase activity Added RELATION part of GO:0018119 (peptidyl-cysteine S-nitrosylation)
2010-11-18 GO:0035606 peptidyl-cysteine S-trans-nitrosylation Added RELATION is a GO:0018119 (peptidyl-cysteine S-nitrosylation)
2010-11-18 GO:0035607 fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development Added RELATION part of GO:0021769 (orbitofrontal cortex development)
2010-11-18 GO:0035607 fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development Added RELATION is a GO:0008543 (fibroblast growth factor receptor signaling pathway)
2010-11-18 GO:0007507 heart development Added RELATION part of GO:0072358 (cardiovascular system development)
2010-11-18 GO:0001944 vasculature development Added RELATION is a GO:0048731 (system development)
2010-11-18 GO:0001944 vasculature development Added RELATION part of GO:0072358 (cardiovascular system development)
2010-11-18 GO:0001944 vasculature development Deleted RELATION is a GO:0048856 (anatomical structure development)
2010-11-18 GO:0000910 cytokinesis Added RELATION part of GO:0051301 (cell division)
2010-11-18 GO:0000910 cytokinesis Added RELATION is a GO:0009987 (cellular process)
2010-11-18 GO:0000910 cytokinesis Deleted RELATION is a GO:0051301 (cell division)
spacer
Please send comments, suggestions or bug reports to goa@ebi.ac.uk. Click here for details of how to cite UniProt-GOA and QuickGO.
101ms